<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy - Perrotta, C - 2022 | Cochrane Library</title> <meta content="Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy - Perrotta, C - 2022 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005259.pub5/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy - Perrotta, C - 2022 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005259.pub5/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD005259.pub5" name="dc.identifier" scheme="DOI"/> <meta content="Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy" name="citation_title"/> <meta content="Carla Perrotta" name="citation_author"/> <meta content="University College Dublin" name="citation_author_institution"/> <meta content="Jorge Chahla" name="citation_author"/> <meta content="Rush University Medical Center" name="citation_author_institution"/> <meta content="Gustavo Badariotti" name="citation_author"/> <meta content="Sanatorio Mater Dei" name="citation_author_institution"/> <meta content="Jorge Ramos" name="citation_author"/> <meta content="Hospital BritÃ¡nico de Buenos Aires" name="citation_author_institution"/> <meta content="jramos@hbritanico.com.ar" name="citation_author_email"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="8" name="citation_issue"/> <meta content="10.1002/14651858.CD005259.pub5" name="citation_doi"/> <meta content="2022" name="citation_date"/> <meta content="2022/08/22" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005259.pub5/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005259.pub5/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005259.pub5/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Anticoagulants [adverse effects]; Arthroscopy [adverse effects]; Aspirin [adverse effects]; Hemorrhage [chemically induced]; Heparin, Low-Molecular-Weight [adverse effects]; Pain [drug therapy]; *Pulmonary Embolism [prevention &amp; control]; Rivaroxaban [adverse effects]; *Venous Thromboembolism [chemically induced]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005259.pub5&amp;doi=10.1002/14651858.CD005259.pub5&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005259.pub5&amp;doi=10.1002/14651858.CD005259.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005259.pub5&amp;doi=10.1002/14651858.CD005259.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005259.pub5&amp;doi=10.1002/14651858.CD005259.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005259.pub5&amp;doi=10.1002/14651858.CD005259.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005259.pub5&amp;doi=10.1002/14651858.CD005259.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005259.pub5&amp;doi=10.1002/14651858.CD005259.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005259.pub5&amp;doi=10.1002/14651858.CD005259.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005259.pub5&amp;doi=10.1002/14651858.CD005259.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005259.pub5&amp;doi=10.1002/14651858.CD005259.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005259.pub5&amp;doi=10.1002/14651858.CD005259.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005259.pub5&amp;doi=10.1002/14651858.CD005259.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005259.pub5&amp;doi=10.1002/14651858.CD005259.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005259.pub5&amp;doi=10.1002/14651858.CD005259.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005259.pub5&amp;doi=10.1002/14651858.CD005259.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005259.pub5&amp;doi=10.1002/14651858.CD005259.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005259.pub5&amp;doi=10.1002/14651858.CD005259.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005259.pub5&amp;doi=10.1002/14651858.CD005259.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005259.pub5&amp;doi=10.1002/14651858.CD005259.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005259.pub5&amp;doi=10.1002/14651858.CD005259.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005259.pub5&amp;doi=10.1002/14651858.CD005259.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005259.pub5&amp;doi=10.1002/14651858.CD005259.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005259.pub5&amp;doi=10.1002/14651858.CD005259.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="xcg9958b";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD005259\x2epub5\x26doi\x3d10\x2e1002\x2f14651858\x2eCD005259\x2epub5\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005259\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005259\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","zh_HANT","ko","pt","ms","fa","fr"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD005259.pub5",title:"Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy",firstPublishedDate:"Aug 22, 2022 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Vascular Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=xcg9958b&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD005259.pub5&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD005259.pub5';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> EspaÃ±ol </option> <option class="content-language-option" data-languagecode="fa" value="fa"> ÙØ§Ø±Ø³Û </option> <option class="content-language-option" data-languagecode="fr" value="fr"> FranÃ§ais </option> <option class="content-language-option" data-languagecode="hi" value="hi"> à¤¹à¤¿à¤¨à¥à¤¦à¥ </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> æ¥æ¬èª </option> <option class="content-language-option" data-languagecode="ko" value="ko"> íêµ­ì´ </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> PortuguÃªs </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Ð ÑÑÑÐºÐ¸Ð¹ </option> <option class="content-language-option" data-languagecode="ro" value="ro"> RomÃ¢nÄ </option> <option class="content-language-option" data-languagecode="ta" value="ta"> à®¤à®®à®¿à®´à¯ </option> <option class="content-language-option" data-languagecode="th" value="th"> à¸ à¸²à¸©à¸²à¹à¸à¸¢ </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> ç¹é«ä¸­æ </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> ç®ä½ä¸­æ </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD005259.pub5/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD005259.pub5/full/es"> EspaÃ±ol </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD005259.pub5%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD005259.pub5/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD005259.pub5/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD005259.pub5/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD005259.pub5/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD005259.PUB5" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;ÚÚ©ÛØ¯Ù&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;RÃ©sumÃ© scientifique&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;ì´ë¡&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Zusammenfassung in einfacher Sprache&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en tÃ©rminos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;Ø®ÙØ§ØµÙ Ø¨Ù Ø²Ø¨Ø§Ù Ø³Ø§Ø¯Ù&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;RÃ©sumÃ© simplifiÃ©&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;ì¬ì´ ë§ ìì½&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo para leigos&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;æ·ºé¡¯ææçå£èªçµè«&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]},{&quot;param&quot;: &quot;comments&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Comments&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD005259.pub5/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD005259.PUB5" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD005259.pub5/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD005259.pub5/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views:Â </span> <span>3173 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD005259.pub5" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005259.pub5/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005259.pub5/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005259.pub5/full#CD005259-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005259.pub5/full#CD005259-sec-0089"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005259.pub5/full#CD005259-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005259.pub5/full#CD005259-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005259.pub5/full#CD005259-sec-0014"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005259.pub5/full#CD005259-sec-0015"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005259.pub5/full#CD005259-sec-0039"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005259.pub5/full#CD005259-sec-0083"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD005259.pub5/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005259.pub5/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005259.pub5/appendices#CD005259-sec-0094"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005259.pub5/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005259.pub5/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD005259.pub5/media/CDSR/CD005259/table_n/CD005259StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD005259.pub5/media/CDSR/CD005259/table_n/CD005259StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005259.pub5/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005259.pub5/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005259.pub5/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD005259.pub5/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD005259.pub5/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD005259.pub5/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright Â© 2022 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD005259.pub5/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005259.pub5/information#CD005259-cr-0004">Carla Perrotta</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005259.pub5/information#CD005259-cr-0005">Jorge Chahla</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005259.pub5/information#CD005259-cr-0006">Gustavo Badariotti</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005259.pub5/information#CD005259-cr-0007"><i class="icon corresponding-author fa fa-envelope"></i>Jorge Ramos</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD005259.pub5/information/en#CD005259-sec-0102">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 22 August 2022 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD005259.pub5/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD005259.pub5">https://doi.org/10.1002/14651858.CD005259.pub5</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD005259-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD005259-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD005259-abs-0014">EspaÃ±ol</a> </li> <li class="section-language"> <a class="" href="full/fa#CD005259-abs-0010">ÙØ§Ø±Ø³Û</a> </li> <li class="section-language"> <a class="" href="full/fr#CD005259-abs-0012">FranÃ§ais</a> </li> <li class="section-language"> <a class="" href="full/ko#CD005259-abs-0005">íêµ­ì´</a> </li> <li class="section-language"> <a class="" href="full/pt#CD005259-abs-0007">PortuguÃªs</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD005259-abs-0001" lang="en"> <section id="CD005259-sec-0001"> <h3 class="title" id="CD005259-sec-0001">Background</h3> <p>Knee arthroscopy (KA) is a routine orthopedic procedure recommended to repair cruciate ligaments and meniscus injuries and, in suitable cases, to assist the diagnosis of persistent knee pain. There is a small risk of thromboembolic events associated with KA. This systematic review aims to assess if pharmacological or nonâpharmacological interventions may reduce this risk. This is an update of an earlier Cochrane Review. </p> </section> <section id="CD005259-sec-0002"> <h3 class="title" id="CD005259-sec-0002">Objectives</h3> <p>To evaluate the efficacy and safety of interventions â whether mechanical, pharmacological, or a combination of both â for thromboprophylaxis in adults undergoing KA. </p> </section> <section id="CD005259-sec-0003"> <h3 class="title" id="CD005259-sec-0003">Search methods</h3> <p>We used standard, extensive Cochrane search methods. The latest search date was 1 June 2021. </p> </section> <section id="CD005259-sec-0004"> <h3 class="title" id="CD005259-sec-0004">Selection criteria</h3> <p>We included randomized controlled trials (RCTs) and controlled clinical trials (CCTs), blinded or unblinded, of all types of interventions used to prevent deep vein thrombosis (DVT) in men and women aged 18 years and older undergoing KA. </p> </section> <section id="CD005259-sec-0005"> <h3 class="title" id="CD005259-sec-0005">Data collection and analysis</h3> <p>We used standard Cochrane methods. Our primary outcomes were pulmonary embolism (PE), symptomatic DVT, asymptomatic DVT, and allâcause mortality. Our secondary outcomes were adverse effects, major bleeding, and minor bleeding. We used GRADE criteria to assess the certainty of the evidence. </p> </section> <section id="CD005259-sec-0006"> <h3 class="title" id="CD005259-sec-0006">Main results</h3> <p>We did not identify any new studies for this update. This review includes eight studies involving 3818 adults with no history of thromboembolic disease. Five studies compared daily subcutaneous lowâmolecularâweight heparin (LMWH) versus no prophylaxis; one study compared oral rivaroxaban 10 mg versus placebo; one study compared daily subcutaneous LMWH versus graduated compression stockings; and one study compared aspirin versus no prophylaxis. </p> <p>The incidence of PE in all studies combined was low, with seven cases in 3818 participants. There were no deaths in any of the intervention or control groups. </p> <p><b>Lowâmolecularâweight heparin versus no prophylaxis</b> </p> <p>When compared with no prophylaxis, LMWH probably results in little to no difference in the incidence of PE in people undergoing KA (risk ratio [RR] 1.81, 95% confidence interval [CI] 0.49 to 6.65; 3 studies, 1820 participants; moderateâcertainty evidence). LMWH may make little or no difference to the incidence of symptomatic DVT (RR 0.61, 95% CI 0.18 to 2.03; 4 studies, 1848 participants; lowâcertainty evidence). It is uncertain whether LMWH reduces the risk of asymptomatic DVT (RR 0.14, 95% CI 0.03 to 0.61; 2 studies, 369 participants; very lowâcertainty evidence). LMWH probably makes little or no difference to the risk of all adverse effects combined (RR 1.85, 95% CI 0.95 to 3.59; 5 studies, 1978 participants; moderateâcertainty evidence), major bleeding (RR 0.98, 95% CI 0.06 to 15.72; 1451 participants; moderateâcertainty evidence), or minor bleeding (RR 1.79, 95% CI 0.84 to 3.84; 5 studies, 1978 participants; moderateâcertainty evidence). </p> <p><b>Rivaroxaban versus placebo</b> </p> <p>One study with 234 participants compared oral rivaroxaban 10 mg versus placebo. There were no cases of PE reported. Rivaroxaban probably led to little or no difference in symptomatic DVT (RR 0.16, 95% CI 0.02 to 1.29; moderateâcertainty evidence). It is uncertain whether rivaroxaban reduces the risk of asymptomatic DVT because the certainty of the evidence is very low (RR 0.95, 95% CI 0.06 to 15.01). The study only reported bleeding adverse effects. No major bleeds occurred in either group, and rivaroxaban probably made little or no difference to minor bleeding (RR 0.63, 95% CI 0.18 to 2.19; moderateâcertainty evidence). </p> <p><b>Aspirin versus no prophylaxis</b> </p> <p>One study compared aspirin with no prophylaxis. There were no PE, DVT or asymptomatic events detected in either group. The study authors reported adverse effects including pain and swelling, but without clarifying which groups these occurred in. There were no bleeds reported. </p> <p><b>Lowâmolecularâweight heparin versus compression stockings</b> </p> <p>One study with 1317 participants compared LMWH versus compression stockings. LMWH may lead to little or no difference in the risk of PE compared to compression stockings (RR 1.00, 95% CI 0.14 to 7.05; lowâcertainty evidence), but it may reduce the risk of symptomatic DVT (RR 0.17, 95% CI 0.04 to 0.75; lowâcertainty evidence). It is uncertain whether LMWH has any effect on asymptomatic DVT (RR 0.47, 95% CI 0.21 to 1.09; very lowâcertainty evidence). The results suggest LMWH probably leads to little or no difference in major bleeding (RR 3.01, 95% CI 0.61 to 14.88; moderateâcertainty evidence), or minor bleeding (RR 1.16, 95% CI 0.64 to 2.08; moderateâcertainty evidence). </p> <p>We downgraded the certainty of the evidence for imprecision due to overall small event numbers, for risk of bias due to concerns about lack of blinding, and for indirectness due to uncertainty about the direct clinical relevance of asymptomatic DVT detection. </p> </section> <section id="CD005259-sec-0007"> <h3 class="title" id="CD005259-sec-0007">Authors' conclusions</h3> <p>There is a small risk that healthy adults undergoing KA will develop venous thromboembolism (PE or DVT). We found moderateâ to lowâcertainty evidence of little or no benefit from LMWH, or rivaroxaban in reducing this small risk of PE or symptomatic DVT. The studies provided very lowâcertainty evidence that LMWH may reduce the risk of asymptomatic DVT compared to no prophylaxis, but it is uncertain how this directly relates to incidence of DVT or PE in healthy people undergoing KA. There is probably little or no difference in adverse effects (including major and minor bleeding), but data relating to these outcomes were limited by low numbers of events in the studies reporting these outcomes. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD005259-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD005259-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD005259-abs-0003">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD005259-abs-0015">EspaÃ±ol</a> </li> <li class="section-language"> <a class="" href="full/fa#CD005259-abs-0011">ÙØ§Ø±Ø³Û</a> </li> <li class="section-language"> <a class="" href="full/fr#CD005259-abs-0013">FranÃ§ais</a> </li> <li class="section-language"> <a class="" href="full/ko#CD005259-abs-0006">íêµ­ì´</a> </li> <li class="section-language"> <a class="" href="full/ms#CD005259-abs-0009">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pt#CD005259-abs-0008">PortuguÃªs</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD005259-abs-0004">ç¹é«ä¸­æ</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD005259-abs-0002" lang="en"> <h3>Treatments for preventing venous thromboembolism in adults who have keyhole surgery of the knee </h3> <p><b>Key message</b> </p> <p>â¢ We did not find clear evidence that the use of clotâpreventing medications (lowâmolecularâweight heparin (LMWH), aspirin or rivaroxaban) in healthy adults who undergo minimally invasive knee surgery can reduce the small risk of blood clots developing in their deep veins, or the small risk that these blood clots travel to a blood vessel in their lungs. </p> <p>â¢ We did not find any clear evidence that LMWH, aspirin or rivaroxaban cause harmful effects such as bleeding in these people. </p> <p><b>Why is this question important?</b> </p> <p>In knee arthroscopy, a healthcare provider inserts a tiny camera through a small cut in the person's knee. Knee arthroscopy is used to diagnose and repair many types of knee injuries. People who undergo this procedure have a small risk of developing a blood clot in the deep veins of their legs (deep vein thrombosis). Those who get deep vein thrombosis may have symptoms such as calf pain or swelling (symptomatic deep vein thrombosis). There is also a risk that the clots may move to the lungs (pulmonary embolism). People who have surgery often receive medications to lower the risk of clots developing. These medications help to prevent blood clots by thinning the blood, and they may cause side effects such as bleeding. Because the risk of getting a blood clot after knee arthroscopy is small, it is important to know if taking medication to prevent clots is necessary. </p> <p><b>What did we do?</b> </p> <p>This systematic review included randomized controlled trials of people who had knee arthroscopy and who either did or did not receive clotâpreventing medication. Randomized studies provide the most reliable evidence about treatment effects because the treatment people receive is decided at random. </p> <p><b>What did we find?</b> </p> <p>In the studies we included in our review, the control participants (those who did not receive medication) received no treatment in six studies, received a dummy pill (placebo) in one study, and wore compression stockings in one study. </p> <p>We combined information from five studies, and this showed that LMWH â a medicine that people inject into their abdominal area every day â does not clearly reduce the risk of pulmonary embolism or symptomatic deep vein thrombosis compared with no treatment. LMWH may reduce the risk of asymptomatic deep vein thrombosis (a clot in the leg without symptoms, usually detected by testing), but we are very uncertain about the results. LMWH had no clear effect on bleeding. </p> <p>In one study, oral rivaroxaban did not reduce the risk of deep vein thrombosis, and also did not increase minor bleeding when compared to placebo. The study reported no cases of pulmonary embolism or major bleeding. </p> <p>In one study that compared aspirin with no treatment, no participants had pulmonary embolism, deep vein thrombosis or bleeding. </p> <p>Compared to compression stockings, LMWH did not reduce pulmonary embolism or bleeding, but did reduce symptomatic deep vein thrombosis. </p> <p><b>How certain are we about the evidence?</b> </p> <p>Our confidence in the evidence differs across treatments and results of treatment. We are not very confident about the evidence for pulmonary embolism and symptomatic deep vein thrombosis because the total number of cases (clots) was small. We are not confident in the evidence on asymptomatic clots because participants were aware of the treatments they had, and may have revealed this information â whether accidentally or on purpose â to the medical staff who were looking for the clots. In addition, asymptomatic clots may be less clinically important in people who are at low risk of clots or who quickly regain mobility after the knee arthroscopy. </p> <p><b>How up to date is this evidence?</b> </p> <p>This Cochrane Review updates our previous evidence. The evidence is current to 1 June 2021. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD005259-sec-0089" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD005259-sec-0089"></div> <h3 class="title" id="CD005259-sec-0090">Implications for practice</h3> <section id="CD005259-sec-0090"> <p>There is a small risk that healthy adults undergoing knee arthroscopy (KA) will develop pulmonary embolism (PE) or deep vein thrombosis (DVT). The studies provided moderateâ to lowâcertainty evidence of little or no benefit from lowâmolecularâweight heparin (LMWH) or rivaroxaban in reducing this small risk of PE or symptomatic DVT. We found very lowâcertainty evidence that LMWH may reduce the risk of asymptomatic DVT compared to no prophylaxis, but we are not sure how this directly relates to the incidence of DVT or PE in healthy people undergoing KA. There is probably little or no difference in adverse effects (including major and minor bleeding), but data relating to this were limited by low numbers of events in the studies reporting these outcomes. </p> </section> <h3 class="title" id="CD005259-sec-0091">Implications for research</h3> <section id="CD005259-sec-0091"> <p>New studies should focus on the benefit of prophylaxis in people at high risk, such as those with obesity, those who are unable to gain early mobility, or those with limited access to acute emergency care. New clinical trials with lowârisk participants would require a very large sample size to record a sufficient number of events. Authors of new studies should minimize the risk of bias by observing participants' trajectories and measuring only symptomatic thromboembolic outcomes, rather than actively seeking venous thromboembolism with diagnostic tests such as compression ultrasound.Â <a href="./references#CD005259-bbs2-0007" title="NCT01542723. Pot-Kast: Thrombosis Prophylaxis After Knee Arthroscopy (Pot-Kast). clinicaltrials.gov/ct2/show/NCT01542723 (first received 2 March 2012). vanAdrichemRA , NemethB , AlgraA , le CessieS , RosendaalFR , SchipperIB , et al. Thromboprophylaxis after knee arthroscopy and lower-leg casting. New England Journal of Medicine2017;376(6):515-25. ">van Adrichem 2017</a>Â exemplifies a study design that can answer the research question without introducing additional bias. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD005259-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD005259-sec-0008"></div> <div class="table" id="CD005259-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 1.</span>Â <span class="table-title">Lowâmolecularâweight heparin compared to no prophylaxis for preventing venous thromboembolism in adults undergoing knee arthroscopy</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>LMWH compared to no prophylaxis for preventing VTE in adults undergoing KA</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> adults undergoing KA<br/><b>Setting:</b> hospital<br/><b>Intervention:</b> LMWH<br/><b>Comparison:</b> no prophylaxis </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Number of participants<br/>(RCTs)</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Interpretation</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Without LMWH</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>With LMWH</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>PE:</b> assessed by CT arteriography (followâup: 30 days to 3 months)<br/>Â  </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>1820<br/>(3 RCTs) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.81</b><br/>(0.49 to 6.65) </p> </td> <th align="" class="headercell" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Study population</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>ââââ<br/><b>Moderate</b><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>LMWH probably leads to little or no difference in rates of PE.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 per 1000 (2 to 22)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Symptomatic DVT:</b> assessed by presence of symptoms and confirmed by a positive compression ultrasound (followâup: 30 days to 3 months)<br/>Â  </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>1848<br/>(4 RCTs) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.61</b><br/>(0.18 to 2.03) </p> </td> <th align="" class="headercell" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Study population</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>ââââ<br/><b>Low</b><sup>b</sup> </p> <p>Â </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>LMWH may lead to little or no difference in symptomatic DVT.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7 per 1000 (2 to 22)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Asymptomatic DVT:</b> assessed with compression ultrasound (followâup: 30 days to 8 weeks) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>369<br/>(2 RCTs) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.14</b><br/>(0.03 to 0.61) </p> </td> <th align="" class="headercell" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Study population</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>ââââ<br/><b>Very low</b><sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>It is uncertain if LMWH reduces the risk asymptomatic DVT.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>81 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11 per 1000 (2 to 49)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Allâcause mortality</b> (followâup: 30 days to 3 months)<br/>Â  </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>1978<br/>(5 RCTs) </p> </td> <td align="" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No deaths occurred in any of the included studies.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>All adverse effects</b>, including allergies at injection site, minor and major bleeding, others (followâup: 30 days to 3 months)<br/>Â  </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>1978<br/>(5 RCTs) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.85</b><br/>(0.95 to 3.59) </p> </td> <th align="" class="headercell" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Study population</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>ââââ</p> <p><b>Moderate</b><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>LMWH probably leads to little or no difference in adverse effects.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24 per 1000<br/>(13 to 47) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Major bleeding</b> (followâup: 30 days to 3 months)<br/>Â  </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>1451<br/>(1 RCT) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.98</b> </p> <p>(0.06 to 15.72).</p> </td> <th align="" class="headercell" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Study population</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>ââââ<br/><b>Moderate</b><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>LMWH probably leads to little or no difference in rates of major bleeding.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 per 1000</p> <p>(0 to 22)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Minor bleeding</b> (followâup: 30 days to 3 months) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>1978<br/>(5 RCTs) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.79</b><br/>(0.84 to 3.84) </p> </td> <th align="" class="headercell" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Study population</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>ââââ<br/><b>Moderate</b><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>LMWH probably leads to little or no difference in rates of minor bleeding.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20 per 1000 (9 to 43)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> confidence interval; <b>CT:</b> computed tomography; <b>DVT:</b> deep vein thrombosis;<b>KA:</b> knee arthroscopy; <b>LMWH:</b> lowâmolecularâweight heparin; <b>PE:</b> pulmonary embolism; <b>RCT:</b> randomized controlled trial; <b>RR:</b> risk ratio; <b>VTE:</b> venous thromboembolism. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level for imprecision.<br/><sup>b</sup>Downgraded two levels for imprecision and risk of bias.<br/><sup>c</sup>Downgraded three levels for imprecision, risk of bias, and indirectness. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD005259-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD005259-sec-0009"></div> <section id="CD005259-sec-0010"> <h3 class="title" id="CD005259-sec-0010">Description of the condition</h3> <p>Knee arthroscopy (KA) is indicated to repair the anterior cruciate ligament (ACL) and meniscal tears, and, in suitable people, to assist the diagnosis of persistent knee pain (<a href="./references#CD005259-bbs2-0011" title="American Academy of Orthopedic Surgeons. Management of Anterior Cruciate Ligament Injuries. Evidence-Based Clinical Practice Guideline. Available at aaos.org/aclcpg 5 September 2014.">AAOS 2014</a>). Complications of KA are uncommon, with rates of less than 1%. The most frequent complications are local hematoma, pyogenic arthritis and thromboembolic events. In a large cohort study of 20,770 KA procedures (<a href="./references#CD005259-bbs2-0026" title="MaletisG , InacioM , ReynoldsS , FunahshiT . Incidence of symptomatic venous thromboembolism after elective knee arthroscopy. Journal of Bone and Joint Surgery2012;94:714-20.">Maletis 2012</a>), the risk of deep vein thrombosis (DVT) was 0.25% (95% confidence interval (CI) 0.18% to 0.31%). For pulmonary embolism (PE), the risk was 0.017% (95% CI 0.11% to 0.22%). Two prospective studies reported incidence rates of asymptomatic DVT of 7.84% to 18% (<a href="./references#CD005259-bbs2-0013" title="DelisKT , HuntN , StrachanRK , NicolaidesAN . Incidence, natural history and risk factors of deep vein thrombosis in elective knee arthroscopy. Thrombosis and Haemostasis2001;86(3):817-21.">Delis 2001</a>;Â <a href="./references#CD005259-bbs2-0014" title="DemersC , MarcouxS , GinsbergJS , LarocheF , CloutierR , PoulinJ . Incidence of venographically proved deep vein thrombosis after knee arthroscopy. Archives of Internal Medicine1998;158(1):47-50.">Demers 1998</a>). The risk of thromboembolic events after KA was higher in participants who smoked, in those taking oral contraceptives, in those with a previous history of thromboembolic diseases, and in those with a body mass index over 30 kg/m<sup>2</sup>. </p> <p>Proximal DVT (DVT above the popliteal vein) increases the risk of PE. Half of people presenting with proximal symptomatic DVT will have evidence of PE in lung scans (<a href="./references#CD005259-bbs2-0023" title="KearonC . Natural history of venous thromboembolism. Circulation2003;107(23 Suppl 1):122-30.">Kearon 2003</a>). Immobilization and limb surgery also increase the risk of thromboembolic disease because of decreased blood flow and an increase in inflammatory markers that activate the coagulation cascade (<a href="./references#CD005259-bbs2-0013" title="DelisKT , HuntN , StrachanRK , NicolaidesAN . Incidence, natural history and risk factors of deep vein thrombosis in elective knee arthroscopy. Thrombosis and Haemostasis2001;86(3):817-21.">Delis 2001</a>;Â <a href="./references#CD005259-bbs2-0026" title="MaletisG , InacioM , ReynoldsS , FunahshiT . Incidence of symptomatic venous thromboembolism after elective knee arthroscopy. Journal of Bone and Joint Surgery2012;94:714-20.">Maletis 2012</a>). The clinical relevance of asymptomatic distal DVT is unclear; the consensus is that isolated asymptomatic calf DVT rarely progresses to symptomatic DVT (<a href="./references#CD005259-bbs2-0016" title="GaskillT , PullenWM , BryantB , SicignanoN , EvansM , DeMaioM . The prevalence of symptomatic deep venous thrombosis and pulmonary embolism after anterior cruciate ligament reconstruction. American Journal of Sports Medicine2015;43(11):2714-9.">Gaskill 2015</a>;Â <a href="./references#CD005259-bbs2-0023" title="KearonC . Natural history of venous thromboembolism. Circulation2003;107(23 Suppl 1):122-30.">Kearon 2003</a>). </p> <p>The accuracy of asymptomatic DVT diagnosis by sonography (ultrasound) varies depending on the technique used: according toÂ <a href="./references#CD005259-bbs2-0017" title="GoodacreS , SampsonF , ThomasS , vanBeekE , SuttonA . Systematic review and meta-analysis of the diagnostic accuracy of ultrasonography for deep vein thrombosis. BMC Medical Imaging2005;5:6.">Goodacre 2005</a>, duplex ultrasound achieves higher sensitivity (71%), while compression ultrasound alone achieves higher specificity (98%). Thromboprophylaxis is recommended in hip replacement and knee replacement surgeries, as thromboembolic events are relatively frequent in those clinical circumstances. Two probable reasons for this are the longer duration of the surgery and the fact that some people are unable to regain early mobility. </p> </section> <section id="CD005259-sec-0011"> <h3 class="title" id="CD005259-sec-0011">Description of the intervention</h3> <p>For pharmacological prophylaxis in orthopedic surgery, clinical guidelines recommend apixaban, aspirin, dabigatran etexilate, fondaparinux sodium, lowâmolecularâweight heparin (LMWH), and rivaroxaban. Where there is a contraindication for any pharmacological strategy, the guidelines recommend using graduated elastic compression stockings and intermittent pneumatic compression (<a href="./references#CD005259-bbs2-0015" title="Falck-YtterY , FrancisCW , JohansonNA , CurleyC , DahlOE , SchulmanS , et al. Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest2012;141(2 Suppl):e278S-325S.">FalckâYtter 2012</a>; <a href="./references#CD005259-bbs2-0027" title="NICE. Venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism. Guideline NG89 (last updated 13 August 2019). www.nice.org.uk/guidance/ng89 (accessed 31 March 2022).">NICE 2019</a>). The aim of all the above interventions is to prevent venous thromboembolism. </p> </section> <section id="CD005259-sec-0012"> <h3 class="title" id="CD005259-sec-0012">How the intervention might work</h3> <p>Pharmacological interventions include parenteral anticoagulants (LMWH, fondaparinux), oral direct thrombin inhibitors (dabigatran), oral factor Xa inhibitors (rivaroxaban and apixaban), and oral antiplatelets (aspirin). They all work by inhibiting stages of the coagulation process (coagulation cascade). LMWH selectively binds to antithrombin (AT; a serine protease inhibitor) and creates a conformational change of the molecule. This change promotes inhibition of activated factor X. Fondaparinux is a synthetic pentasaccharide factor Xa inhibitor; it also works by binding to AT, but it is selective for factor Xa (<a href="./references#CD005259-bbs2-0029" title="RitterJM , FlowerRJ , HendersonG , LokeYK , MacEwanD , RangHP . Rang &amp; Dale's Pharmacology E-Book. 9th edition. Amsterdam: Elsevier, 2019. [DOI: 9780702074462]">Ritter 2019</a>). Dabigatran reversibly binds to the active site on the thrombin molecule, preventing thrombinâmediated activation of coagulation factors (<a href="./references#CD005259-bbs2-0029" title="RitterJM , FlowerRJ , HendersonG , LokeYK , MacEwanD , RangHP . Rang &amp; Dale's Pharmacology E-Book. 9th edition. Amsterdam: Elsevier, 2019. [DOI: 9780702074462]">Ritter 2019</a>). Rivaroxaban inhibits both free factor Xa and factor Xa bound in the prothrombinase complex. It is a highly selective direct factor Xa inhibitor with a rapid onset of action. Aspirin inhibits platelet generation of thromboxane A2, resulting in an antithrombotic effect (<a href="./references#CD005259-bbs2-0029" title="RitterJM , FlowerRJ , HendersonG , LokeYK , MacEwanD , RangHP . Rang &amp; Dale's Pharmacology E-Book. 9th edition. Amsterdam: Elsevier, 2019. [DOI: 9780702074462]">Ritter 2019</a>). Mechanical interventions facilitate the circulation of the venous flow in lower limbs, preventing thrombus formation (<a href="./references#CD005259-bbs2-0012" title="BenkoT , CookeEA , McNallyMA , MollanRA . Graduated compression stockings: knee length or thigh length. Clinical Orthopaedics and Related Research2001;383:197-203.">Benko 2001</a>). </p> </section> <section id="CD005259-sec-0013"> <h3 class="title" id="CD005259-sec-0013">Why it is important to do this review</h3> <p>It is relevant to clinical practice to determine whether thromboprophylaxis reduces the already low risk of thromboembolic disease in people undergoing common procedures such as KA. Whether prophylaxis used routinely in orthopedic surgery should also be used in KA remains unclear, owing to the very low risk of severe thromboembolic events (proximal DVT and PE), the uncertain significance of asymptomatic distal DVT (which is also of low prevalence), and the fact that people quickly regain mobility after the procedure. To assist decisionâmaking, it is important to present upâtoâdate evidence on thromboprophylaxis in people undergoing KA who have no previous history of thromboembolic events. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD005259-sec-0014" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD005259-sec-0014"></div> <p>To evaluate the efficacy and safety of interventions â whether mechanical, pharmacological, or a combination of both â for thromboprophylaxis in adults undergoing KA. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD005259-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD005259-sec-0015"></div> <section id="CD005259-sec-0016"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD005259-sec-0017"> <h4 class="title">Types of studies</h4> <p>We included randomized controlled trials (RCTs) and controlled clinical trials (CCTs), regardless of blinding (i.e. doubleâblind, singleâblind and unblinded trials were eligible for inclusion). </p> </section> <section id="CD005259-sec-0018"> <h4 class="title">Types of participants</h4> <p>Eligible studies included adults (aged 18 years and older) undergoing KA.</p> </section> <section id="CD005259-sec-0019"> <h4 class="title">Types of interventions</h4> <p>We included any type of pharmacological or mechanical intervention, whether used singly or in combination, to prevent DVT in adults undergoing KA. We excluded interventions involving arthroscopically assisted osteosynthesis of tibial plateau fractures. </p> </section> <section id="CD005259-sec-0020"> <h4 class="title">Types of outcome measures</h4> <section id="CD005259-sec-0021"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD005259-list-0001"> <li> <p>PE confirmed by ventilation/perfusion (V/Q) lung scan, spiral computed tomography (CT), or pulmonary angiography </p> </li> <li> <p>Symptomatic DVT (distal and proximal combined), diagnosed clinically, venographically or sonographically, and defined as symptomatic when participants spontaneously experienced DVT symptoms (calf pain, swelling, edema) or when participants referred to symptoms of DVT while undergoing echoâDoppler or compression ultrasound in the context of the study </p> </li> <li> <p>Asymptomatic DVT, defined as asymptomatic when participants were actively screened for DVT using echoâDoppler or compression ultrasound and did not indicate any symptoms during ultrasound </p> </li> <li> <p>Allâcause mortality</p> </li> </ul> </p> </section> <section id="CD005259-sec-0022"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD005259-list-0002"> <li> <p>All reported adverse effects (pain, allergies, minor and major bleeding)</p> </li> <li> <p>Major bleeding (overt and requiring transfusion of red blood cells or surgical intervention, and which may lead to permanent disability) </p> </li> <li> <p>Minor bleeding (not meeting the criteria for intervention), including hematoma, hemarthrosis and thrombocytopenia (reduction of circulating platelets) with a platelet count below 80,000/mm<sup>3</sup> or less than half of the initial count </p> </li> </ul> </p> </section> </section> </section> <section id="CD005259-sec-0023"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD005259-sec-0024"> <h4 class="title">Electronic searches</h4> <p>The Cochrane Vascular Information Specialist conducted systematic searches of the following databases for RCTs and CCTs, with no restrictions on language, publication year or publication status. </p> <p> <ul id="CD005259-list-0003"> <li> <p>The Cochrane Vascular Specialised Register via the Cochrane Register of Studies (CRSâWeb, searched 1 June 2021). </p> </li> <li> <p>The Cochrane Central Register of Controlled Trials (CENTRAL) Cochrane Register of Studies Online (2021, Issue 5). </p> </li> <li> <p>MEDLINE: Ovid MEDLINE Epub Ahead of Print, InâProcess &amp; Other NonâIndexed Citations, Ovid MEDLINE Daily and Ovid MEDLINE (searched 14 August 2019 to 1 June 2021). </p> </li> <li> <p>Embase Ovid (searched 14 August 2019 to 1 June 2021).</p> </li> <li> <p>CINAHL Ebsco (searched 14 August 2019 to 1 June 2021).</p> </li> <li> <p>AMED Ovid (searched 14 August 2019 to 1 June 2021).</p> </li> </ul> </p> <p>The Information Specialist modeled search strategies for other databases on the search strategy designed for CENTRAL. Where appropriate, strategies were combined with adaptations of the highly sensitive search strategy designed by Cochrane for identifying RCTs and CCTs, as described in Chapter 6 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD005259-bbs2-0025" title="LefebvreC , GlanvilleJ , BriscoeS , LittlewoodA , MarshallC , MetzendorfMI , et al. Chapter 4: Searching for and selecting studies. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from training.cochrane.org/handbook/archive/v6.2/.">Lefebvre 2021</a>). Search strategies for major databases are provided in Appendix 1. </p> <p>The Information Specialist searched the following trials registries on 1 June 2021.</p> <p> <ul id="CD005259-list-0004"> <li> <p>The World Health Organization International Clinical Trials Registry Platform (<a href="https://who.int/clinical-trials-registry-platform" target="_blank">who.int/clinical-trials-registry-platform</a>). </p> </li> <li> <p>ClinicalTrials.gov (<a href="http://clinicaltrials.gov" target="_blank">clinicaltrials.gov</a>). </p> </li> </ul> </p> </section> <section id="CD005259-sec-0025"> <h4 class="title">Searching other resources</h4> <p>We searched the reference lists of identified studies for additional citations.</p> </section> </section> <section id="CD005259-sec-0026"> <h3 class="title" id="CD005259-sec-0026">Data collection and analysis</h3> <section id="CD005259-sec-0027"> <h4 class="title">Selection of studies</h4> <p>Two authors (CP, JR) independently screened the initial reference list, identified relevant citations, and used a standardized form to determine whether they met the inclusion criteria. </p> </section> <section id="CD005259-sec-0028"> <h4 class="title">Data extraction and management</h4> <p>Three authors (JR, JC, GB) extracted the data into a custom spreadsheet before entering them into Review Manager 5 (<a href="./references#CD005259-bbs2-0028" title="Nordic Cochrane Centre, The Cochrane CollaborationReview Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.">Review Manager 2014</a>). If necessary, we planned to contact study authors for additional information or data. </p> </section> <section id="CD005259-sec-0029"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Using RoB 1 (<a href="./references#CD005259-bbs2-0021" title="HigginsJP , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1/.">Higgins 2011</a>), three review authors (JC, JR, GB) independently assessed the risk of bias for each of the included studies according to the following domains. </p> <p> <ul id="CD005259-list-0005"> <li> <p>Sequence generation (selection bias).</p> </li> <li> <p>Allocation concealment (selection bias).</p> </li> <li> <p>Blinding of participants and personnel (performance bias).</p> </li> <li> <p>Blinding of outcome assessors (ascertainment bias).</p> </li> <li> <p>Incomplete outcome data (attrition bias).</p> </li> <li> <p>Selective outcome reporting bias.</p> </li> <li> <p>Other sources of bias.</p> </li> </ul> </p> <p>The review authors judged whether each study was at low, high or unclear risk of bias in each domain. An unclear risk of bias judgement could be due to lack of information or uncertainty over the potential for bias. Disagreements among review authors were resolved by consensus. </p> </section> <section id="CD005259-sec-0030"> <h4 class="title">Measures of treatment effect</h4> <p>We investigated the treatment effect on our outcomes of interest by calculating risk ratios (RRs) with 95% CIs. We planned to include clinical trials that had zero events. None of our outcomes were continuous. </p> </section> <section id="CD005259-sec-0031"> <h4 class="title">Unit of analysis issues</h4> <p>We considered individual participants to be the units of randomization in the included studies. In the original protocol, we stated that the unit of analysis would be the knee (<a href="./references#CD005259-bbs2-0031" title="RamosJ , PerrottaC , BeresteinG , BadariottiG , PerrotaC , BerensteinEG . Anticoagulation for thrombotic prophylaxis in knee arthroscopy. Cochrane Database of Systematic Reviews2005, Issue 2. Art. No: CD005259. [DOI: 10.1002/14651858.CD005259]">Ramos 2005</a>), but no included studies enrolled people undergoing bilateral KA. </p> </section> <section id="CD005259-sec-0032"> <h4 class="title">Dealing with missing data</h4> <p>Had we identified any studies with missing data for the relevant outcomes (thromboembolic events and adverse effects), we would have contacted the authors to request the missing data. </p> </section> <section id="CD005259-sec-0033"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed the heterogeneity of estimated effects in the included studies by visually inspecting the forest plot generated from the metaâanalysis of studies. We assessed statistical heterogeneity using the IÂ² statistic (<a href="./references#CD005259-bbs2-0020" title="HigginsJP , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta-analyses. BMJ2003;327:557-60.">Higgins 2003</a>). Very divergent results or IÂ² greater than 50% were considered to represent substantial heterogeneity. We also used the ChiÂ² statistic, assuming statistically significant heterogeneity where ChiÂ² exceeded the degrees of freedom (df) and the P value was less than 0.05. If heterogeneity was present, we aimed to explore sources of heterogeneity that could be relevant to the clinical question. </p> </section> <section id="CD005259-sec-0034"> <h4 class="title">Assessment of reporting biases</h4> <p>If we had included sufficient studies (10 or more) in the metaâanalysis, we would have assessed the presence of publication bias and other reporting bias using funnel plots (<a href="./references#CD005259-bbs2-0021" title="HigginsJP , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1/.">Higgins 2011</a>). </p> </section> <section id="CD005259-sec-0035"> <h4 class="title">Data synthesis</h4> <p>Where studies compared similar interventions and reported comparable outcomes, we pooled effect estimates using the inverse variance method through a fixedâeffect model, and calculated 95% CIs. </p> <p>If heterogeneity was present, we used a randomâeffects model and, where possible, carried out subgroup analyses to explain the source of heterogeneity. We reported the results narratively when metaâanalysis was not possible. </p> <p>We used Review Manager 5 to perform the analyses (<a href="./references#CD005259-bbs2-0028" title="Nordic Cochrane Centre, The Cochrane CollaborationReview Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.">Review Manager 2014</a>). </p> </section> <section id="CD005259-sec-0036"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We did not have any preplanned subgroup analyses. To investigate heterogeneity, we attempted to explain differences as per study design by looking at subgroups of studies, specifically how the outcomes were defined and assessed. </p> </section> <section id="CD005259-sec-0037"> <h4 class="title">Sensitivity analysis</h4> <p>We carried out a sensitivity analysis to determine any impact of using either intentionâtoâtreat (ITT) data or perâprotocol (PP) data in <a href="./references#CD005259-bbs2-0007" title="NCT01542723. Pot-Kast: Thrombosis Prophylaxis After Knee Arthroscopy (Pot-Kast). clinicaltrials.gov/ct2/show/NCT01542723 (first received 2 March 2012). vanAdrichemRA , NemethB , AlgraA , le CessieS , RosendaalFR , SchipperIB , et al. Thromboprophylaxis after knee arthroscopy and lower-leg casting. New England Journal of Medicine2017;376(6):515-25. ">van Adrichem 2017</a>. </p> </section> <section id="CD005259-sec-0038"> <h4 class="title">Summary of findings and assessment of the certainty of the evidence</h4> <p>UsingÂ <a href="./references#CD005259-bbs2-0018" title="McMaster University (developed by Evidence Prime)GRADEpro GDT. Version accessed 16 July 2019. Hamilton, ON: McMaster University (developed by Evidence Prime). Available at gradepro.org.">GRADEpro GDT</a>, we prepared a summary of findings table to present the main findings from the metaâanalysis for the outcomes of PE, symptomatic DVT, asymptomatic DVT, allâcause mortality, all adverse effects, major bleeding and minor bleeding. </p> <p>We created a summary of findings table for the comparison of LMWH versus no prophylaxis but not for the remaining comparisons, which were based on data from single studies. </p> <p>Using the GRADE criteria, we ranked the certainty of the evidence for each outcome based on risk of bias, inconsistency, indirectness, imprecision and publication bias (<a href="./references#CD005259-bbs2-0019" title="GuyattGH , OxmanAD , VistGE , KunzR , Falck-YtterY , Alonso-CoelloP , et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ2008;336(7650):924-6.">Guyatt 2008</a>), justifying all decisions to downgrade the certainty of the evidence. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD005259-sec-0039" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD005259-sec-0039"></div> <section id="CD005259-sec-0040"> <h3 class="title">Description of studies</h3> <section id="CD005259-sec-0041"> <h4 class="title">Results of the search</h4> <p>See <a href="#CD005259-fig-0001">Figure 1</a>. The searches retrieved a total of 755 records. After removing duplicates, we screened 631 records, considering all of them to be clearly irrelevant. We did not include any new studies in this update; nor did we assess any new excluded or ongoing studies. </p> <div class="figure" id="CD005259-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Flow diagram" data-id="CD005259-fig-0001" src="/cdsr/doi/10.1002/14651858.CD005259.pub5/media/CDSR/CD005259/image_n/nCD005259-FIG-01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Flow diagram</p> </div> </div> </div> </section> <section id="CD005259-sec-0042"> <h4 class="title">Included studies</h4> <p>See theÂ <a href="./references#CD005259-sec-0108" title="">Characteristics of included studies</a>Â table for further details. </p> <p>To date, we have included a total of eight studies with 3818 participants in our review (<a href="./references#CD005259-bbs2-0001" title="CamporeseG , BernardiE , N'TitaK , VerlatoF , SalmistraroG , CordovaR , et al. Different thromboprophylaxis approaches in patients undergoing knee arthroscopy (KANT Study): a prospective randomized study. Journal of Thrombosis and Haemostasis2005;3(1):Abstract number: P1618. CamporeseG , BernardiE , PrandoniP , NoventaF , VerlatoF , CordovaR , et al. Graduated compression stockings versus low molecular- weight heparin for prevention of deep vein thrombosis after knee arthroscopy: a randomized trial. Pathophysiology of Haemostasis and Thrombosis2008;36(Suppl 1):A21. CamporeseG , BernardiE , PrandoniP , NoventaF , VerlatoF , SimioniP , et al. Low-molecular-weight heparin versus compression stockings for thromboprophylaxis after knee arthroscopy: a randomized trial. Annals of Internal Medicine2008;149(2):73-82. CamporeseG , N'TitaK , RossiF , BernardiE , VerlatoF , SalmistraroG , et al. Different thromboprophylaxis approaches in patients undergoing knee arthroscopy (KANT study): interim report of prospective randomized study. Journal of Thrombosis and Haemostasis2003;1(Suppl 1):Abstract P1888. ">Camporese 2008</a>;Â <a href="./references#CD005259-bbs2-0002" title="CamporeseG , BernardiE , NoventaF , BoscoM , BortoluzzC , MazzolaC , et al. Efficacy of rivaroxaban for prevention of venous thromboembolism after knee arthroscopy. a randomized double-blind trial (Erika study). International Angiology2014;33(Suppl 1):35. CamporeseG , BernardiE , NoventaF , BoscoM , MonteleoneG , SantoroL , et al. Efficacy of Rivaroxaban for thromboprophylaxis after Knee Arthroscopy (ERIKA). A phase II, multicentre, double-blind, placebo-controlled randomised study. Thrombosis and Haemostasis2016;116(2):349-55. CamporeseG , BernardiE , NoventaF . Efficacy of rivaroxaban for prevention of venous thromboembolism after knee arthroscopy: a randomized double-blind trial (ERIKA study). Journal of thrombosis and haemostasis2015;13:204. ">Camporese 2016</a>;Â <a href="./references#CD005259-bbs2-0003" title="CanataGL , ChieyA . Prevention of venous thromboembolism after ACL reconstruction: a prospective, randomized study. ISAKOS (International Society of Arthroscopy, Knee Surgery and Orthopaedic Sports Medicine)2003;Poster 71-2003. ">Canata 2003</a>;Â <a href="./references#CD005259-bbs2-0004" title="KayeID , PatelDN , StraussEJ , AlaiaMJ , GarofoloG , MartinezA , et al. Prevention of venous thromboembolism after arthroscopic knee surgery in a low-risk population with the use of aspirin. A randomized trial. Bulletin of the Hospital for Joint Diseases2015;73(4):234-8. ">Kaye 2015</a>;Â <a href="./references#CD005259-bbs2-0005" title="MichotM , ConenD , HoltzD , ErniD , ZumsteinMD , RuflinGB , et al. Prevention of deep-vein thrombosis in ambulatory arthroscopic knee surgery: a randomized trial of prophylaxis with low-molecular weight heparin. Arthroscopy2002;18(3):257-63. ">Michot 2002</a>;Â <a href="./references#CD005259-bbs2-0006" title="RothP . Prophylaxis of deep vein thrombosis in outpatients undergoing arthroscopic meniscus operation [Thromboembolieprophylaxe bei ambulant durchgefÃ¼rten arthroskopischen Meniskusoperationen]. OrthopÃ¤dische Praxis1995;5:345-8. ">Roth 1995</a>;Â <a href="./references#CD005259-bbs2-0007" title="NCT01542723. Pot-Kast: Thrombosis Prophylaxis After Knee Arthroscopy (Pot-Kast). clinicaltrials.gov/ct2/show/NCT01542723 (first received 2 March 2012). vanAdrichemRA , NemethB , AlgraA , le CessieS , RosendaalFR , SchipperIB , et al. Thromboprophylaxis after knee arthroscopy and lower-leg casting. New England Journal of Medicine2017;376(6):515-25. ">van Adrichem 2017</a>;Â <a href="./references#CD005259-bbs2-0008" title="WirthT , SchneiderB , MisselwitzF , LombM , TÃ¼ylÃ¼H , EgbringR , et al. Prevention of venous thromboembolism after knee arthroscopy with low-molecular weight heparin (Reviparin): results of a randomized controlled trial. Arthroscopy2001;17(4):393-9. ">Wirth 2001</a>). </p> <p>Overall, the included studies investigated four different treatments for the prevention of thromboembolic disease in adults undergoing KA. </p> <p>Pregnancy, cancer and previous thromboembolic disease were exclusion criteria in most studies.Â <a href="./references#CD005259-bbs2-0004" title="KayeID , PatelDN , StraussEJ , AlaiaMJ , GarofoloG , MartinezA , et al. Prevention of venous thromboembolism after arthroscopic knee surgery in a low-risk population with the use of aspirin. A randomized trial. Bulletin of the Hospital for Joint Diseases2015;73(4):234-8. ">Kaye 2015</a>Â excluded smokers, andÂ <a href="./references#CD005259-bbs2-0008" title="WirthT , SchneiderB , MisselwitzF , LombM , TÃ¼ylÃ¼H , EgbringR , et al. Prevention of venous thromboembolism after knee arthroscopy with low-molecular weight heparin (Reviparin): results of a randomized controlled trial. Arthroscopy2001;17(4):393-9. ">Wirth 2001</a>Â excluded people with three or more of a predefined set of risk factors (obesity, nicotine abuse, oral contraceptives, family history of thrombosis). </p> <p>Five studies, with a total of 1942 participants, compared LMWH to no prophylaxis (<a href="./references#CD005259-bbs2-0003" title="CanataGL , ChieyA . Prevention of venous thromboembolism after ACL reconstruction: a prospective, randomized study. ISAKOS (International Society of Arthroscopy, Knee Surgery and Orthopaedic Sports Medicine)2003;Poster 71-2003. ">Canata 2003</a>;Â <a href="./references#CD005259-bbs2-0005" title="MichotM , ConenD , HoltzD , ErniD , ZumsteinMD , RuflinGB , et al. Prevention of deep-vein thrombosis in ambulatory arthroscopic knee surgery: a randomized trial of prophylaxis with low-molecular weight heparin. Arthroscopy2002;18(3):257-63. ">Michot 2002</a>;Â <a href="./references#CD005259-bbs2-0006" title="RothP . Prophylaxis of deep vein thrombosis in outpatients undergoing arthroscopic meniscus operation [Thromboembolieprophylaxe bei ambulant durchgefÃ¼rten arthroskopischen Meniskusoperationen]. OrthopÃ¤dische Praxis1995;5:345-8. ">Roth 1995</a>;Â <a href="./references#CD005259-bbs2-0007" title="NCT01542723. Pot-Kast: Thrombosis Prophylaxis After Knee Arthroscopy (Pot-Kast). clinicaltrials.gov/ct2/show/NCT01542723 (first received 2 March 2012). vanAdrichemRA , NemethB , AlgraA , le CessieS , RosendaalFR , SchipperIB , et al. Thromboprophylaxis after knee arthroscopy and lower-leg casting. New England Journal of Medicine2017;376(6):515-25. ">van Adrichem 2017</a>;Â <a href="./references#CD005259-bbs2-0008" title="WirthT , SchneiderB , MisselwitzF , LombM , TÃ¼ylÃ¼H , EgbringR , et al. Prevention of venous thromboembolism after knee arthroscopy with low-molecular weight heparin (Reviparin): results of a randomized controlled trial. Arthroscopy2001;17(4):393-9. ">Wirth 2001</a>). One study with 241 participants compared rivaroxaban to placebo (<a href="./references#CD005259-bbs2-0002" title="CamporeseG , BernardiE , NoventaF , BoscoM , BortoluzzC , MazzolaC , et al. Efficacy of rivaroxaban for prevention of venous thromboembolism after knee arthroscopy. a randomized double-blind trial (Erika study). International Angiology2014;33(Suppl 1):35. CamporeseG , BernardiE , NoventaF , BoscoM , MonteleoneG , SantoroL , et al. Efficacy of Rivaroxaban for thromboprophylaxis after Knee Arthroscopy (ERIKA). A phase II, multicentre, double-blind, placebo-controlled randomised study. Thrombosis and Haemostasis2016;116(2):349-55. CamporeseG , BernardiE , NoventaF . Efficacy of rivaroxaban for prevention of venous thromboembolism after knee arthroscopy: a randomized double-blind trial (ERIKA study). Journal of thrombosis and haemostasis2015;13:204. ">Camporese 2016</a>). One study with 170 participants compared aspirin to no prophylaxis (<a href="./references#CD005259-bbs2-0004" title="KayeID , PatelDN , StraussEJ , AlaiaMJ , GarofoloG , MartinezA , et al. Prevention of venous thromboembolism after arthroscopic knee surgery in a low-risk population with the use of aspirin. A randomized trial. Bulletin of the Hospital for Joint Diseases2015;73(4):234-8. ">Kaye 2015</a>). One study with 1317 participants compared LMWH for seven or 14 days to use of compression stockings (<a href="./references#CD005259-bbs2-0001" title="CamporeseG , BernardiE , N'TitaK , VerlatoF , SalmistraroG , CordovaR , et al. Different thromboprophylaxis approaches in patients undergoing knee arthroscopy (KANT Study): a prospective randomized study. Journal of Thrombosis and Haemostasis2005;3(1):Abstract number: P1618. CamporeseG , BernardiE , PrandoniP , NoventaF , VerlatoF , CordovaR , et al. Graduated compression stockings versus low molecular- weight heparin for prevention of deep vein thrombosis after knee arthroscopy: a randomized trial. Pathophysiology of Haemostasis and Thrombosis2008;36(Suppl 1):A21. CamporeseG , BernardiE , PrandoniP , NoventaF , VerlatoF , SimioniP , et al. Low-molecular-weight heparin versus compression stockings for thromboprophylaxis after knee arthroscopy: a randomized trial. Annals of Internal Medicine2008;149(2):73-82. CamporeseG , N'TitaK , RossiF , BernardiE , VerlatoF , SalmistraroG , et al. Different thromboprophylaxis approaches in patients undergoing knee arthroscopy (KANT study): interim report of prospective randomized study. Journal of Thrombosis and Haemostasis2003;1(Suppl 1):Abstract P1888. ">Camporese 2008</a>). </p> <p>All studies evaluated thromboembolic disease (PE, symptomatic DVT, asymptomatic DVT, or a combination of these), mortality, minor and major bleeding or other adverse effects. </p> <p>The types of KA performed were meniscectomy, ACL reconstruction and removal of loose fragments and, in a small proportion of participants, diagnostic procedures. Most of the studies did not tabulate events in relation to the type of surgery performed or to participant characteristics such as body mass index or smoking status. </p> </section> <section id="CD005259-sec-0043"> <h4 class="title">Excluded studies</h4> <p>No studies reached the fullâtext review stage in this update, so we did not assess any new excluded studies. We reassessed one study that we had considered irrelevant in the previous version of this review (<a href="./references#CD005259-bbs2-0010" title="MuÃ±oaL , GonzÃ¡lezAB , DÃ­az de RadaP , ValentÃ­A , ValentÃ­JR . Rivaroxaban is as efficient and safe as bemiparin as thromboprophylaxis in knee arthroscopy. Musculoskeletal Surgery2014;98(1):21-5. [DOI: 10.1007/s12306-013-0287-7]">MuÃ±oa 2014</a>), to confirm our decision. This was a nonârandomized study that compared rivaroxaban with bemiparin after KA. On reassessment, we maintained that it should not be included.Â <a href="./references#CD005259-bbs2-0009" title="MarlovitsS , StriessnigG , SchusterR , StockerR , LuxlM , TrattnigR , et al. A prospective, randomized, placebo-controlled study of extended-duration post-discharge thromboprophylaxis with enoxaparin following arthroscopic reconstruction of the anterior cruciate ligament. Blood2004;104(11 Part 1):Abstract 1764. MarlovitsS , StriessnigG , SchusterR , StockerR , LuxlM , TrattnigS , et al. Extended-duration thromboprophylaxis with enoxaparin after arthroscopic surgery of the anterior cruciate ligament: a prospective, randomized, placebo-controlled study. Arthroscopy2007;23(7):696-702. ">Marlovits 2004</a>Â was excluded previously as it compared LMWH treatment for three to eight days with LMWH for 20 days, without a control arm. See theÂ <a href="./references#CD005259-sec-0109" title="">Characteristics of excluded studies</a>Â table for further details. </p> </section> </section> <section id="CD005259-sec-0044"> <h3 class="title">Risk of bias in included studies</h3> <p>SeeÂ <a href="#CD005259-fig-0002">Figure 2</a>Â andÂ <a href="#CD005259-fig-0003">Figure 3</a>Â for a summary of the overall risk of bias. </p> <div class="figure" id="CD005259-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgments about each risk of bias item presented as percentages across all included studies." data-id="CD005259-fig-0002" src="/cdsr/doi/10.1002/14651858.CD005259.pub5/media/CDSR/CD005259/image_n/nCD005259-FIG-02.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgments about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD005259-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgments about each risk of bias item for each included study." data-id="CD005259-fig-0003" src="/cdsr/doi/10.1002/14651858.CD005259.pub5/media/CDSR/CD005259/image_n/nCD005259-FIG-03.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgments about each risk of bias item for each included study. </p> </div> </div> </div> <p>Overall, the included studies were of acceptable methodological quality, given the type of intervention. We judged no studies at high risk of bias in relation to randomization, allocation, selection bias or reporting bias. We flagged a few issues, such as a lack of participant or personnel blinding, and the lack of a placebo in the studies comparing LMWH to no prophylaxis. We believe that the lack of placebo would not have impacted more objective outcomes such as death, PE or symptomatic DVT (participants seeking medical advice due to DVT symptoms with confirmation by a positive echoâDoppler or compression ultrasound). There is a risk of bias in outcomes that could be influenced by study personnel or participants being aware of, or disclosing, participant status in treatment arms. </p> <p>All studies exceptÂ <a href="./references#CD005259-bbs2-0007" title="NCT01542723. Pot-Kast: Thrombosis Prophylaxis After Knee Arthroscopy (Pot-Kast). clinicaltrials.gov/ct2/show/NCT01542723 (first received 2 March 2012). vanAdrichemRA , NemethB , AlgraA , le CessieS , RosendaalFR , SchipperIB , et al. Thromboprophylaxis after knee arthroscopy and lower-leg casting. New England Journal of Medicine2017;376(6):515-25. ">van Adrichem 2017</a>Â included asymptomatic venous thrombosis in their combined outcome.Â <a href="./references#CD005259-bbs2-0001" title="CamporeseG , BernardiE , N'TitaK , VerlatoF , SalmistraroG , CordovaR , et al. Different thromboprophylaxis approaches in patients undergoing knee arthroscopy (KANT Study): a prospective randomized study. Journal of Thrombosis and Haemostasis2005;3(1):Abstract number: P1618. CamporeseG , BernardiE , PrandoniP , NoventaF , VerlatoF , CordovaR , et al. Graduated compression stockings versus low molecular- weight heparin for prevention of deep vein thrombosis after knee arthroscopy: a randomized trial. Pathophysiology of Haemostasis and Thrombosis2008;36(Suppl 1):A21. CamporeseG , BernardiE , PrandoniP , NoventaF , VerlatoF , SimioniP , et al. Low-molecular-weight heparin versus compression stockings for thromboprophylaxis after knee arthroscopy: a randomized trial. Annals of Internal Medicine2008;149(2):73-82. CamporeseG , N'TitaK , RossiF , BernardiE , VerlatoF , SalmistraroG , et al. Different thromboprophylaxis approaches in patients undergoing knee arthroscopy (KANT study): interim report of prospective randomized study. Journal of Thrombosis and Haemostasis2003;1(Suppl 1):Abstract P1888. ">Camporese 2008</a>Â andÂ <a href="./references#CD005259-bbs2-0005" title="MichotM , ConenD , HoltzD , ErniD , ZumsteinMD , RuflinGB , et al. Prevention of deep-vein thrombosis in ambulatory arthroscopic knee surgery: a randomized trial of prophylaxis with low-molecular weight heparin. Arthroscopy2002;18(3):257-63. ">Michot 2002</a>Â identified symptomatic DVT by actively asking participants, during study visits or through telephone interviews, if they had any symptoms of DVT (e.g. calf pain, edema, redness), followed by colorâcoded Doppler (<a href="./references#CD005259-bbs2-0001" title="CamporeseG , BernardiE , N'TitaK , VerlatoF , SalmistraroG , CordovaR , et al. Different thromboprophylaxis approaches in patients undergoing knee arthroscopy (KANT Study): a prospective randomized study. Journal of Thrombosis and Haemostasis2005;3(1):Abstract number: P1618. CamporeseG , BernardiE , PrandoniP , NoventaF , VerlatoF , CordovaR , et al. Graduated compression stockings versus low molecular- weight heparin for prevention of deep vein thrombosis after knee arthroscopy: a randomized trial. Pathophysiology of Haemostasis and Thrombosis2008;36(Suppl 1):A21. CamporeseG , BernardiE , PrandoniP , NoventaF , VerlatoF , SimioniP , et al. Low-molecular-weight heparin versus compression stockings for thromboprophylaxis after knee arthroscopy: a randomized trial. Annals of Internal Medicine2008;149(2):73-82. CamporeseG , N'TitaK , RossiF , BernardiE , VerlatoF , SalmistraroG , et al. Different thromboprophylaxis approaches in patients undergoing knee arthroscopy (KANT study): interim report of prospective randomized study. Journal of Thrombosis and Haemostasis2003;1(Suppl 1):Abstract P1888. ">Camporese 2008</a>), or compression ultrasonography (<a href="./references#CD005259-bbs2-0005" title="MichotM , ConenD , HoltzD , ErniD , ZumsteinMD , RuflinGB , et al. Prevention of deep-vein thrombosis in ambulatory arthroscopic knee surgery: a randomized trial of prophylaxis with low-molecular weight heparin. Arthroscopy2002;18(3):257-63. ">Michot 2002</a>). We considered that there is an unclear risk of bias, due to indirectness of the outcome in the case ofÂ <a href="./references#CD005259-bbs2-0001" title="CamporeseG , BernardiE , N'TitaK , VerlatoF , SalmistraroG , CordovaR , et al. Different thromboprophylaxis approaches in patients undergoing knee arthroscopy (KANT Study): a prospective randomized study. Journal of Thrombosis and Haemostasis2005;3(1):Abstract number: P1618. CamporeseG , BernardiE , PrandoniP , NoventaF , VerlatoF , CordovaR , et al. Graduated compression stockings versus low molecular- weight heparin for prevention of deep vein thrombosis after knee arthroscopy: a randomized trial. Pathophysiology of Haemostasis and Thrombosis2008;36(Suppl 1):A21. CamporeseG , BernardiE , PrandoniP , NoventaF , VerlatoF , SimioniP , et al. Low-molecular-weight heparin versus compression stockings for thromboprophylaxis after knee arthroscopy: a randomized trial. Annals of Internal Medicine2008;149(2):73-82. CamporeseG , N'TitaK , RossiF , BernardiE , VerlatoF , SalmistraroG , et al. Different thromboprophylaxis approaches in patients undergoing knee arthroscopy (KANT study): interim report of prospective randomized study. Journal of Thrombosis and Haemostasis2003;1(Suppl 1):Abstract P1888. ">Camporese 2008</a>Â (a Doppler sonograph is not a usual procedure after KA), and because actively asking participants about their symptoms before performing a Doppler ultrasound could introduce recall bias. There are also differences in the accuracy of the methods of determining DVT (symptomatic and asymptomatic) in both studies (<a href="./references#CD005259-bbs2-0017" title="GoodacreS , SampsonF , ThomasS , vanBeekE , SuttonA . Systematic review and meta-analysis of the diagnostic accuracy of ultrasonography for deep vein thrombosis. BMC Medical Imaging2005;5:6.">Goodacre 2005</a>). We addressed the impact of any potential bias on our confidence in the effect estimates of individual outcomes while assessing the certainty of evidence with GRADE. </p> <section id="CD005259-sec-0045"> <h4 class="title">Allocation</h4> <p>We considered allocation to be adequate in five studies, where randomization strategies included using sealed opaque envelopes; using sequentially numbered, unlabeled boxes; and blinding research staff to block sizes (<a href="./references#CD005259-bbs2-0001" title="CamporeseG , BernardiE , N'TitaK , VerlatoF , SalmistraroG , CordovaR , et al. Different thromboprophylaxis approaches in patients undergoing knee arthroscopy (KANT Study): a prospective randomized study. Journal of Thrombosis and Haemostasis2005;3(1):Abstract number: P1618. CamporeseG , BernardiE , PrandoniP , NoventaF , VerlatoF , CordovaR , et al. Graduated compression stockings versus low molecular- weight heparin for prevention of deep vein thrombosis after knee arthroscopy: a randomized trial. Pathophysiology of Haemostasis and Thrombosis2008;36(Suppl 1):A21. CamporeseG , BernardiE , PrandoniP , NoventaF , VerlatoF , SimioniP , et al. Low-molecular-weight heparin versus compression stockings for thromboprophylaxis after knee arthroscopy: a randomized trial. Annals of Internal Medicine2008;149(2):73-82. CamporeseG , N'TitaK , RossiF , BernardiE , VerlatoF , SalmistraroG , et al. Different thromboprophylaxis approaches in patients undergoing knee arthroscopy (KANT study): interim report of prospective randomized study. Journal of Thrombosis and Haemostasis2003;1(Suppl 1):Abstract P1888. ">Camporese 2008</a>;Â <a href="./references#CD005259-bbs2-0002" title="CamporeseG , BernardiE , NoventaF , BoscoM , BortoluzzC , MazzolaC , et al. Efficacy of rivaroxaban for prevention of venous thromboembolism after knee arthroscopy. a randomized double-blind trial (Erika study). International Angiology2014;33(Suppl 1):35. CamporeseG , BernardiE , NoventaF , BoscoM , MonteleoneG , SantoroL , et al. Efficacy of Rivaroxaban for thromboprophylaxis after Knee Arthroscopy (ERIKA). A phase II, multicentre, double-blind, placebo-controlled randomised study. Thrombosis and Haemostasis2016;116(2):349-55. CamporeseG , BernardiE , NoventaF . Efficacy of rivaroxaban for prevention of venous thromboembolism after knee arthroscopy: a randomized double-blind trial (ERIKA study). Journal of thrombosis and haemostasis2015;13:204. ">Camporese 2016</a>;Â <a href="./references#CD005259-bbs2-0004" title="KayeID , PatelDN , StraussEJ , AlaiaMJ , GarofoloG , MartinezA , et al. Prevention of venous thromboembolism after arthroscopic knee surgery in a low-risk population with the use of aspirin. A randomized trial. Bulletin of the Hospital for Joint Diseases2015;73(4):234-8. ">Kaye 2015</a>;Â <a href="./references#CD005259-bbs2-0007" title="NCT01542723. Pot-Kast: Thrombosis Prophylaxis After Knee Arthroscopy (Pot-Kast). clinicaltrials.gov/ct2/show/NCT01542723 (first received 2 March 2012). vanAdrichemRA , NemethB , AlgraA , le CessieS , RosendaalFR , SchipperIB , et al. Thromboprophylaxis after knee arthroscopy and lower-leg casting. New England Journal of Medicine2017;376(6):515-25. ">van Adrichem 2017</a>;Â <a href="./references#CD005259-bbs2-0008" title="WirthT , SchneiderB , MisselwitzF , LombM , TÃ¼ylÃ¼H , EgbringR , et al. Prevention of venous thromboembolism after knee arthroscopy with low-molecular weight heparin (Reviparin): results of a randomized controlled trial. Arthroscopy2001;17(4):393-9. ">Wirth 2001</a>). We judged these studies at low risk of selection bias. The remaining three studies did not provide sufficient information to prove adequate allocation concealment, and were therefore judged at unclear risk of selection bias (<a href="./references#CD005259-bbs2-0003" title="CanataGL , ChieyA . Prevention of venous thromboembolism after ACL reconstruction: a prospective, randomized study. ISAKOS (International Society of Arthroscopy, Knee Surgery and Orthopaedic Sports Medicine)2003;Poster 71-2003. ">Canata 2003</a>;Â <a href="./references#CD005259-bbs2-0005" title="MichotM , ConenD , HoltzD , ErniD , ZumsteinMD , RuflinGB , et al. Prevention of deep-vein thrombosis in ambulatory arthroscopic knee surgery: a randomized trial of prophylaxis with low-molecular weight heparin. Arthroscopy2002;18(3):257-63. ">Michot 2002</a>;Â <a href="./references#CD005259-bbs2-0006" title="RothP . Prophylaxis of deep vein thrombosis in outpatients undergoing arthroscopic meniscus operation [Thromboembolieprophylaxe bei ambulant durchgefÃ¼rten arthroskopischen Meniskusoperationen]. OrthopÃ¤dische Praxis1995;5:345-8. ">Roth 1995</a>). </p> </section> <section id="CD005259-sec-0046"> <h4 class="title">Blinding</h4> <p><a href="./references#CD005259-bbs2-0002" title="CamporeseG , BernardiE , NoventaF , BoscoM , BortoluzzC , MazzolaC , et al. Efficacy of rivaroxaban for prevention of venous thromboembolism after knee arthroscopy. a randomized double-blind trial (Erika study). International Angiology2014;33(Suppl 1):35. CamporeseG , BernardiE , NoventaF , BoscoM , MonteleoneG , SantoroL , et al. Efficacy of Rivaroxaban for thromboprophylaxis after Knee Arthroscopy (ERIKA). A phase II, multicentre, double-blind, placebo-controlled randomised study. Thrombosis and Haemostasis2016;116(2):349-55. CamporeseG , BernardiE , NoventaF . Efficacy of rivaroxaban for prevention of venous thromboembolism after knee arthroscopy: a randomized double-blind trial (ERIKA study). Journal of thrombosis and haemostasis2015;13:204. ">Camporese 2016</a>Â used oral medications as the intervention and a placebo in the control group. This study was at low risk of both performance and detection bias, as participants, personnel and outcome assessors were blinded to the treatment group. InÂ <a href="./references#CD005259-bbs2-0007" title="NCT01542723. Pot-Kast: Thrombosis Prophylaxis After Knee Arthroscopy (Pot-Kast). clinicaltrials.gov/ct2/show/NCT01542723 (first received 2 March 2012). vanAdrichemRA , NemethB , AlgraA , le CessieS , RosendaalFR , SchipperIB , et al. Thromboprophylaxis after knee arthroscopy and lower-leg casting. New England Journal of Medicine2017;376(6):515-25. ">van Adrichem 2017</a>, participants were aware of their treatment arm, but outcomes were assessed by checking hospital registries. In this case, therefore, lack of blinding should not have influenced outcome measurement. In five studies, the participants or personnel were aware of the treatment group, though the outcome assessors were not (<a href="./references#CD005259-bbs2-0001" title="CamporeseG , BernardiE , N'TitaK , VerlatoF , SalmistraroG , CordovaR , et al. Different thromboprophylaxis approaches in patients undergoing knee arthroscopy (KANT Study): a prospective randomized study. Journal of Thrombosis and Haemostasis2005;3(1):Abstract number: P1618. CamporeseG , BernardiE , PrandoniP , NoventaF , VerlatoF , CordovaR , et al. Graduated compression stockings versus low molecular- weight heparin for prevention of deep vein thrombosis after knee arthroscopy: a randomized trial. Pathophysiology of Haemostasis and Thrombosis2008;36(Suppl 1):A21. CamporeseG , BernardiE , PrandoniP , NoventaF , VerlatoF , SimioniP , et al. Low-molecular-weight heparin versus compression stockings for thromboprophylaxis after knee arthroscopy: a randomized trial. Annals of Internal Medicine2008;149(2):73-82. CamporeseG , N'TitaK , RossiF , BernardiE , VerlatoF , SalmistraroG , et al. Different thromboprophylaxis approaches in patients undergoing knee arthroscopy (KANT study): interim report of prospective randomized study. Journal of Thrombosis and Haemostasis2003;1(Suppl 1):Abstract P1888. ">Camporese 2008</a>;Â <a href="./references#CD005259-bbs2-0003" title="CanataGL , ChieyA . Prevention of venous thromboembolism after ACL reconstruction: a prospective, randomized study. ISAKOS (International Society of Arthroscopy, Knee Surgery and Orthopaedic Sports Medicine)2003;Poster 71-2003. ">Canata 2003</a>;Â <a href="./references#CD005259-bbs2-0004" title="KayeID , PatelDN , StraussEJ , AlaiaMJ , GarofoloG , MartinezA , et al. Prevention of venous thromboembolism after arthroscopic knee surgery in a low-risk population with the use of aspirin. A randomized trial. Bulletin of the Hospital for Joint Diseases2015;73(4):234-8. ">Kaye 2015</a>;Â <a href="./references#CD005259-bbs2-0005" title="MichotM , ConenD , HoltzD , ErniD , ZumsteinMD , RuflinGB , et al. Prevention of deep-vein thrombosis in ambulatory arthroscopic knee surgery: a randomized trial of prophylaxis with low-molecular weight heparin. Arthroscopy2002;18(3):257-63. ">Michot 2002</a>;Â <a href="./references#CD005259-bbs2-0008" title="WirthT , SchneiderB , MisselwitzF , LombM , TÃ¼ylÃ¼H , EgbringR , et al. Prevention of venous thromboembolism after knee arthroscopy with low-molecular weight heparin (Reviparin): results of a randomized controlled trial. Arthroscopy2001;17(4):393-9. ">Wirth 2001</a>). We considered that lack of blinding would not have affected the outcomes of PE, symptomatic DVT or adverse effects, but may have influenced the assessment of asymptomatic DVT. We judged these studies at unclear risk of performance and detection bias. We also consideredÂ <a href="./references#CD005259-bbs2-0006" title="RothP . Prophylaxis of deep vein thrombosis in outpatients undergoing arthroscopic meniscus operation [Thromboembolieprophylaxe bei ambulant durchgefÃ¼rten arthroskopischen Meniskusoperationen]. OrthopÃ¤dische Praxis1995;5:345-8. ">Roth 1995</a>Â at unclear risk of performance and detection bias because it provided insufficient information. </p> </section> <section id="CD005259-sec-0047"> <h4 class="title">Incomplete outcome data</h4> <p>We considered five studies at low risk of attrition bias because they reported complete outcome data, or because any losses to followâup were accounted for and balanced between groups (<a href="./references#CD005259-bbs2-0001" title="CamporeseG , BernardiE , N'TitaK , VerlatoF , SalmistraroG , CordovaR , et al. Different thromboprophylaxis approaches in patients undergoing knee arthroscopy (KANT Study): a prospective randomized study. Journal of Thrombosis and Haemostasis2005;3(1):Abstract number: P1618. CamporeseG , BernardiE , PrandoniP , NoventaF , VerlatoF , CordovaR , et al. Graduated compression stockings versus low molecular- weight heparin for prevention of deep vein thrombosis after knee arthroscopy: a randomized trial. Pathophysiology of Haemostasis and Thrombosis2008;36(Suppl 1):A21. CamporeseG , BernardiE , PrandoniP , NoventaF , VerlatoF , SimioniP , et al. Low-molecular-weight heparin versus compression stockings for thromboprophylaxis after knee arthroscopy: a randomized trial. Annals of Internal Medicine2008;149(2):73-82. CamporeseG , N'TitaK , RossiF , BernardiE , VerlatoF , SalmistraroG , et al. Different thromboprophylaxis approaches in patients undergoing knee arthroscopy (KANT study): interim report of prospective randomized study. Journal of Thrombosis and Haemostasis2003;1(Suppl 1):Abstract P1888. ">Camporese 2008</a>;Â <a href="./references#CD005259-bbs2-0002" title="CamporeseG , BernardiE , NoventaF , BoscoM , BortoluzzC , MazzolaC , et al. Efficacy of rivaroxaban for prevention of venous thromboembolism after knee arthroscopy. a randomized double-blind trial (Erika study). International Angiology2014;33(Suppl 1):35. CamporeseG , BernardiE , NoventaF , BoscoM , MonteleoneG , SantoroL , et al. Efficacy of Rivaroxaban for thromboprophylaxis after Knee Arthroscopy (ERIKA). A phase II, multicentre, double-blind, placebo-controlled randomised study. Thrombosis and Haemostasis2016;116(2):349-55. CamporeseG , BernardiE , NoventaF . Efficacy of rivaroxaban for prevention of venous thromboembolism after knee arthroscopy: a randomized double-blind trial (ERIKA study). Journal of thrombosis and haemostasis2015;13:204. ">Camporese 2016</a>;Â <a href="./references#CD005259-bbs2-0004" title="KayeID , PatelDN , StraussEJ , AlaiaMJ , GarofoloG , MartinezA , et al. Prevention of venous thromboembolism after arthroscopic knee surgery in a low-risk population with the use of aspirin. A randomized trial. Bulletin of the Hospital for Joint Diseases2015;73(4):234-8. ">Kaye 2015</a>;Â <a href="./references#CD005259-bbs2-0005" title="MichotM , ConenD , HoltzD , ErniD , ZumsteinMD , RuflinGB , et al. Prevention of deep-vein thrombosis in ambulatory arthroscopic knee surgery: a randomized trial of prophylaxis with low-molecular weight heparin. Arthroscopy2002;18(3):257-63. ">Michot 2002</a>;Â <a href="./references#CD005259-bbs2-0008" title="WirthT , SchneiderB , MisselwitzF , LombM , TÃ¼ylÃ¼H , EgbringR , et al. Prevention of venous thromboembolism after knee arthroscopy with low-molecular weight heparin (Reviparin): results of a randomized controlled trial. Arthroscopy2001;17(4):393-9. ">Wirth 2001</a>).Â <a href="./references#CD005259-bbs2-0007" title="NCT01542723. Pot-Kast: Thrombosis Prophylaxis After Knee Arthroscopy (Pot-Kast). clinicaltrials.gov/ct2/show/NCT01542723 (first received 2 March 2012). vanAdrichemRA , NemethB , AlgraA , le CessieS , RosendaalFR , SchipperIB , et al. Thromboprophylaxis after knee arthroscopy and lower-leg casting. New England Journal of Medicine2017;376(6):515-25. ">van Adrichem 2017</a>Â described losses and reported results from PP and ITT analyses. As there were no differences in the estimates, we judged the risk of attrition bias to be low. The authors of some studies reported combined outcomes and individual outcomes (all thromboembolic events, including DVT, PE and asymptomatic DVT), so we were able to report the outcomes of interest individually. We judgedÂ <a href="./references#CD005259-bbs2-0006" title="RothP . Prophylaxis of deep vein thrombosis in outpatients undergoing arthroscopic meniscus operation [Thromboembolieprophylaxe bei ambulant durchgefÃ¼rten arthroskopischen Meniskusoperationen]. OrthopÃ¤dische Praxis1995;5:345-8. ">Roth 1995</a>Â at unclear risk of attrition bias because it provided incomplete information on dropouts or losses to followâup. We judgedÂ <a href="./references#CD005259-bbs2-0003" title="CanataGL , ChieyA . Prevention of venous thromboembolism after ACL reconstruction: a prospective, randomized study. ISAKOS (International Society of Arthroscopy, Knee Surgery and Orthopaedic Sports Medicine)2003;Poster 71-2003. ">Canata 2003</a>Â at unclear risk of attrition bias because there were no details on missing data or losses to followâup. </p> </section> <section id="CD005259-sec-0048"> <h4 class="title">Selective reporting</h4> <p>We judged seven studies at low risk of reporting bias as there were no concerns in relation to selective reporting (<a href="./references#CD005259-bbs2-0001" title="CamporeseG , BernardiE , N'TitaK , VerlatoF , SalmistraroG , CordovaR , et al. Different thromboprophylaxis approaches in patients undergoing knee arthroscopy (KANT Study): a prospective randomized study. Journal of Thrombosis and Haemostasis2005;3(1):Abstract number: P1618. CamporeseG , BernardiE , PrandoniP , NoventaF , VerlatoF , CordovaR , et al. Graduated compression stockings versus low molecular- weight heparin for prevention of deep vein thrombosis after knee arthroscopy: a randomized trial. Pathophysiology of Haemostasis and Thrombosis2008;36(Suppl 1):A21. CamporeseG , BernardiE , PrandoniP , NoventaF , VerlatoF , SimioniP , et al. Low-molecular-weight heparin versus compression stockings for thromboprophylaxis after knee arthroscopy: a randomized trial. Annals of Internal Medicine2008;149(2):73-82. CamporeseG , N'TitaK , RossiF , BernardiE , VerlatoF , SalmistraroG , et al. Different thromboprophylaxis approaches in patients undergoing knee arthroscopy (KANT study): interim report of prospective randomized study. Journal of Thrombosis and Haemostasis2003;1(Suppl 1):Abstract P1888. ">Camporese 2008</a>;Â <a href="./references#CD005259-bbs2-0002" title="CamporeseG , BernardiE , NoventaF , BoscoM , BortoluzzC , MazzolaC , et al. Efficacy of rivaroxaban for prevention of venous thromboembolism after knee arthroscopy. a randomized double-blind trial (Erika study). International Angiology2014;33(Suppl 1):35. CamporeseG , BernardiE , NoventaF , BoscoM , MonteleoneG , SantoroL , et al. Efficacy of Rivaroxaban for thromboprophylaxis after Knee Arthroscopy (ERIKA). A phase II, multicentre, double-blind, placebo-controlled randomised study. Thrombosis and Haemostasis2016;116(2):349-55. CamporeseG , BernardiE , NoventaF . Efficacy of rivaroxaban for prevention of venous thromboembolism after knee arthroscopy: a randomized double-blind trial (ERIKA study). Journal of thrombosis and haemostasis2015;13:204. ">Camporese 2016</a>;Â <a href="./references#CD005259-bbs2-0003" title="CanataGL , ChieyA . Prevention of venous thromboembolism after ACL reconstruction: a prospective, randomized study. ISAKOS (International Society of Arthroscopy, Knee Surgery and Orthopaedic Sports Medicine)2003;Poster 71-2003. ">Canata 2003</a>;Â <a href="./references#CD005259-bbs2-0004" title="KayeID , PatelDN , StraussEJ , AlaiaMJ , GarofoloG , MartinezA , et al. Prevention of venous thromboembolism after arthroscopic knee surgery in a low-risk population with the use of aspirin. A randomized trial. Bulletin of the Hospital for Joint Diseases2015;73(4):234-8. ">Kaye 2015</a>;Â <a href="./references#CD005259-bbs2-0005" title="MichotM , ConenD , HoltzD , ErniD , ZumsteinMD , RuflinGB , et al. Prevention of deep-vein thrombosis in ambulatory arthroscopic knee surgery: a randomized trial of prophylaxis with low-molecular weight heparin. Arthroscopy2002;18(3):257-63. ">Michot 2002</a>;Â <a href="./references#CD005259-bbs2-0007" title="NCT01542723. Pot-Kast: Thrombosis Prophylaxis After Knee Arthroscopy (Pot-Kast). clinicaltrials.gov/ct2/show/NCT01542723 (first received 2 March 2012). vanAdrichemRA , NemethB , AlgraA , le CessieS , RosendaalFR , SchipperIB , et al. Thromboprophylaxis after knee arthroscopy and lower-leg casting. New England Journal of Medicine2017;376(6):515-25. ">van Adrichem 2017</a>;Â <a href="./references#CD005259-bbs2-0008" title="WirthT , SchneiderB , MisselwitzF , LombM , TÃ¼ylÃ¼H , EgbringR , et al. Prevention of venous thromboembolism after knee arthroscopy with low-molecular weight heparin (Reviparin): results of a randomized controlled trial. Arthroscopy2001;17(4):393-9. ">Wirth 2001</a>).Â <a href="./references#CD005259-bbs2-0006" title="RothP . Prophylaxis of deep vein thrombosis in outpatients undergoing arthroscopic meniscus operation [Thromboembolieprophylaxe bei ambulant durchgefÃ¼rten arthroskopischen Meniskusoperationen]. OrthopÃ¤dische Praxis1995;5:345-8. ">Roth 1995</a>Â did not have complete reporting for all the outcomes of interest, and so was judged at unclear risk of reporting bias. </p> </section> <section id="CD005259-sec-0049"> <h4 class="title">Other potential sources of bias</h4> <p>InÂ <a href="./references#CD005259-bbs2-0001" title="CamporeseG , BernardiE , N'TitaK , VerlatoF , SalmistraroG , CordovaR , et al. Different thromboprophylaxis approaches in patients undergoing knee arthroscopy (KANT Study): a prospective randomized study. Journal of Thrombosis and Haemostasis2005;3(1):Abstract number: P1618. CamporeseG , BernardiE , PrandoniP , NoventaF , VerlatoF , CordovaR , et al. Graduated compression stockings versus low molecular- weight heparin for prevention of deep vein thrombosis after knee arthroscopy: a randomized trial. Pathophysiology of Haemostasis and Thrombosis2008;36(Suppl 1):A21. CamporeseG , BernardiE , PrandoniP , NoventaF , VerlatoF , SimioniP , et al. Low-molecular-weight heparin versus compression stockings for thromboprophylaxis after knee arthroscopy: a randomized trial. Annals of Internal Medicine2008;149(2):73-82. CamporeseG , N'TitaK , RossiF , BernardiE , VerlatoF , SalmistraroG , et al. Different thromboprophylaxis approaches in patients undergoing knee arthroscopy (KANT study): interim report of prospective randomized study. Journal of Thrombosis and Haemostasis2003;1(Suppl 1):Abstract P1888. ">Camporese 2008</a>, the data and safety monitoring board stopped the 14âday treatment group during a planned interim analysis. The study continued with two groups (7âday treatment versus no prophylaxis). We were unsure if this could have biased the results, so we judged there to be an unclear risk of other bias. InÂ <a href="./references#CD005259-bbs2-0005" title="MichotM , ConenD , HoltzD , ErniD , ZumsteinMD , RuflinGB , et al. Prevention of deep-vein thrombosis in ambulatory arthroscopic knee surgery: a randomized trial of prophylaxis with low-molecular weight heparin. Arthroscopy2002;18(3):257-63. ">Michot 2002</a>, the trialists stopped recruiting before reaching the desired sample size because they considered it unethical to withhold LMWH from the control participants. We judged this study at unclear risk of other bias. All remaining studies were at low risk of other bias. </p> </section> </section> <section id="CD005259-sec-0050"> <h3 class="title" id="CD005259-sec-0050">Effects of interventions</h3> <p>See: <a href="./full#CD005259-tbl-0001"><b>Summary of findings 1</b> Lowâmolecularâweight heparin compared to no prophylaxis for preventing venous thromboembolism in adults undergoing knee arthroscopy</a> </p> <section id="CD005259-sec-0051"> <h4 class="title">Lowâmolecularâweight heparin versus no prophylaxis</h4> <section id="CD005259-sec-0052"> <h5 class="title">Pulmonary embolism</h5> <p>Of the five studies comparing LMWH to no prophylaxis (<a href="./references#CD005259-bbs2-0003" title="CanataGL , ChieyA . Prevention of venous thromboembolism after ACL reconstruction: a prospective, randomized study. ISAKOS (International Society of Arthroscopy, Knee Surgery and Orthopaedic Sports Medicine)2003;Poster 71-2003. ">Canata 2003</a>;Â <a href="./references#CD005259-bbs2-0005" title="MichotM , ConenD , HoltzD , ErniD , ZumsteinMD , RuflinGB , et al. Prevention of deep-vein thrombosis in ambulatory arthroscopic knee surgery: a randomized trial of prophylaxis with low-molecular weight heparin. Arthroscopy2002;18(3):257-63. ">Michot 2002</a>;Â <a href="./references#CD005259-bbs2-0006" title="RothP . Prophylaxis of deep vein thrombosis in outpatients undergoing arthroscopic meniscus operation [Thromboembolieprophylaxe bei ambulant durchgefÃ¼rten arthroskopischen Meniskusoperationen]. OrthopÃ¤dische Praxis1995;5:345-8. ">Roth 1995</a>;Â <a href="./references#CD005259-bbs2-0007" title="NCT01542723. Pot-Kast: Thrombosis Prophylaxis After Knee Arthroscopy (Pot-Kast). clinicaltrials.gov/ct2/show/NCT01542723 (first received 2 March 2012). vanAdrichemRA , NemethB , AlgraA , le CessieS , RosendaalFR , SchipperIB , et al. Thromboprophylaxis after knee arthroscopy and lower-leg casting. New England Journal of Medicine2017;376(6):515-25. ">van Adrichem 2017</a>;Â <a href="./references#CD005259-bbs2-0008" title="WirthT , SchneiderB , MisselwitzF , LombM , TÃ¼ylÃ¼H , EgbringR , et al. Prevention of venous thromboembolism after knee arthroscopy with low-molecular weight heparin (Reviparin): results of a randomized controlled trial. Arthroscopy2001;17(4):393-9. ">Wirth 2001</a>), three reported on PE (<a href="./references#CD005259-bbs2-0005" title="MichotM , ConenD , HoltzD , ErniD , ZumsteinMD , RuflinGB , et al. Prevention of deep-vein thrombosis in ambulatory arthroscopic knee surgery: a randomized trial of prophylaxis with low-molecular weight heparin. Arthroscopy2002;18(3):257-63. ">Michot 2002</a>;Â <a href="./references#CD005259-bbs2-0007" title="NCT01542723. Pot-Kast: Thrombosis Prophylaxis After Knee Arthroscopy (Pot-Kast). clinicaltrials.gov/ct2/show/NCT01542723 (first received 2 March 2012). vanAdrichemRA , NemethB , AlgraA , le CessieS , RosendaalFR , SchipperIB , et al. Thromboprophylaxis after knee arthroscopy and lower-leg casting. New England Journal of Medicine2017;376(6):515-25. ">van Adrichem 2017</a>;Â <a href="./references#CD005259-bbs2-0008" title="WirthT , SchneiderB , MisselwitzF , LombM , TÃ¼ylÃ¼H , EgbringR , et al. Prevention of venous thromboembolism after knee arthroscopy with low-molecular weight heparin (Reviparin): results of a randomized controlled trial. Arthroscopy2001;17(4):393-9. ">Wirth 2001</a>). Overall, there were few events, and pooling the data from these showed no clear difference in the rates of PE in the LMWH group compared to the control group (6/914 with LMWH versus 3/906 with control; RR 1.81, 95% CI 0.49 to 6.65; 3 studies, 1820 participants; moderateâcertainty evidence;Â <a href="./references#CD005259-fig-0004" title="">Analysis 1.1</a>). We downgraded the certainty of the evidence by one level for imprecision around the estimate of effect. </p> </section> <section id="CD005259-sec-0053"> <h5 class="title">Symptomatic deep vein thrombosis</h5> <p>Four studies reported symptomatic DVT as a separate outcome (<a href="./references#CD005259-bbs2-0003" title="CanataGL , ChieyA . Prevention of venous thromboembolism after ACL reconstruction: a prospective, randomized study. ISAKOS (International Society of Arthroscopy, Knee Surgery and Orthopaedic Sports Medicine)2003;Poster 71-2003. ">Canata 2003</a>;Â <a href="./references#CD005259-bbs2-0006" title="RothP . Prophylaxis of deep vein thrombosis in outpatients undergoing arthroscopic meniscus operation [Thromboembolieprophylaxe bei ambulant durchgefÃ¼rten arthroskopischen Meniskusoperationen]. OrthopÃ¤dische Praxis1995;5:345-8. ">Roth 1995</a>;Â <a href="./references#CD005259-bbs2-0007" title="NCT01542723. Pot-Kast: Thrombosis Prophylaxis After Knee Arthroscopy (Pot-Kast). clinicaltrials.gov/ct2/show/NCT01542723 (first received 2 March 2012). vanAdrichemRA , NemethB , AlgraA , le CessieS , RosendaalFR , SchipperIB , et al. Thromboprophylaxis after knee arthroscopy and lower-leg casting. New England Journal of Medicine2017;376(6):515-25. ">van Adrichem 2017</a>;Â <a href="./references#CD005259-bbs2-0008" title="WirthT , SchneiderB , MisselwitzF , LombM , TÃ¼ylÃ¼H , EgbringR , et al. Prevention of venous thromboembolism after knee arthroscopy with low-molecular weight heparin (Reviparin): results of a randomized controlled trial. Arthroscopy2001;17(4):393-9. ">Wirth 2001</a>). There was no clear difference in the rates of symptomatic DVT when comparing LMWH to no prophylaxis (RR 0.61, 95% CI 0.18 to 2.03; 4 studies, 1848 participants; lowâcertainty evidence;Â <a href="./references#CD005259-fig-0005" title="">Analysis 1.2</a>). We downgraded the certainty of the evidence by one level for imprecision due to the small absolute number of events and small sample size, and by one level for risk of bias due to lack of a valid placebo, uncertainty about blinding and reporting of symptoms with potential recall bias. </p> </section> <section id="CD005259-sec-0054"> <h5 class="title">Asymptomatic deep vein thrombosis</h5> <p>Two studies reported on asymptomatic DVT (<a href="./references#CD005259-bbs2-0005" title="MichotM , ConenD , HoltzD , ErniD , ZumsteinMD , RuflinGB , et al. Prevention of deep-vein thrombosis in ambulatory arthroscopic knee surgery: a randomized trial of prophylaxis with low-molecular weight heparin. Arthroscopy2002;18(3):257-63. ">Michot 2002</a>;Â <a href="./references#CD005259-bbs2-0008" title="WirthT , SchneiderB , MisselwitzF , LombM , TÃ¼ylÃ¼H , EgbringR , et al. Prevention of venous thromboembolism after knee arthroscopy with low-molecular weight heparin (Reviparin): results of a randomized controlled trial. Arthroscopy2001;17(4):393-9. ">Wirth 2001</a>). Compared to no prophylaxis, LMWH may reduce the prevalence of DVT diagnosed by compression ultrasonography, but the evidence is very uncertain (RR 0.14, 95% CI 0.03 to 0.61; 2 studies, 369 participants; very lowâcertainty evidence;Â <a href="./references#CD005259-fig-0006" title="">Analysis 1.3</a>). </p> <p>We downgraded the evidence by three levels for imprecision, risk of bias and indirectness. The use of compression ultrasonography to actively look for asymptomatic DVT is not routinely recommended in KA. Participants were not blinded to the intervention, and there is a possibility that they discussed their allocation intervention with assessors. Additionally, this is not an outcome of interest in participants who are at low risk of thromboembolic disease or who will regain full mobility within a week of the procedure. </p> </section> <section id="CD005259-sec-0055"> <h5 class="title">Allâcause mortality</h5> <p>No deaths occurred in any study.</p> </section> <section id="CD005259-sec-0056"> <h5 class="title">All reported adverse effects (pain, allergies, minor and major bleeding)</h5> <p>The five studies reported 39 adverse effects in 1978 participants (<a href="./references#CD005259-bbs2-0003" title="CanataGL , ChieyA . Prevention of venous thromboembolism after ACL reconstruction: a prospective, randomized study. ISAKOS (International Society of Arthroscopy, Knee Surgery and Orthopaedic Sports Medicine)2003;Poster 71-2003. ">Canata 2003</a>;Â <a href="./references#CD005259-bbs2-0005" title="MichotM , ConenD , HoltzD , ErniD , ZumsteinMD , RuflinGB , et al. Prevention of deep-vein thrombosis in ambulatory arthroscopic knee surgery: a randomized trial of prophylaxis with low-molecular weight heparin. Arthroscopy2002;18(3):257-63. ">Michot 2002</a>;Â <a href="./references#CD005259-bbs2-0006" title="RothP . Prophylaxis of deep vein thrombosis in outpatients undergoing arthroscopic meniscus operation [Thromboembolieprophylaxe bei ambulant durchgefÃ¼rten arthroskopischen Meniskusoperationen]. OrthopÃ¤dische Praxis1995;5:345-8. ">Roth 1995</a>;Â <a href="./references#CD005259-bbs2-0007" title="NCT01542723. Pot-Kast: Thrombosis Prophylaxis After Knee Arthroscopy (Pot-Kast). clinicaltrials.gov/ct2/show/NCT01542723 (first received 2 March 2012). vanAdrichemRA , NemethB , AlgraA , le CessieS , RosendaalFR , SchipperIB , et al. Thromboprophylaxis after knee arthroscopy and lower-leg casting. New England Journal of Medicine2017;376(6):515-25. ">van Adrichem 2017</a>;Â <a href="./references#CD005259-bbs2-0008" title="WirthT , SchneiderB , MisselwitzF , LombM , TÃ¼ylÃ¼H , EgbringR , et al. Prevention of venous thromboembolism after knee arthroscopy with low-molecular weight heparin (Reviparin): results of a randomized controlled trial. Arthroscopy2001;17(4):393-9. ">Wirth 2001</a>). Adverse effects included minor bleeding at the injection site, pain at the injection site, and allergies manifesting as inflammation at the injection site. No studies assessed thrombocytopenia. LMWH had no clear effect on risk of all adverse effects combined (RR 1.85, 95% CI 0.95 to 3.59; 5 studies, 1978 participants; moderateâcertainty evidence;Â <a href="./references#CD005259-fig-0007" title="">Analysis 1.4</a>). We downgraded the certainty of the evidence by one level for imprecision due to the low numbers of events. </p> </section> <section id="CD005259-sec-0057"> <h5 class="title">Major bleeding</h5> <p>Only one study reported any cases of major bleeding (<a href="./references#CD005259-bbs2-0007" title="NCT01542723. Pot-Kast: Thrombosis Prophylaxis After Knee Arthroscopy (Pot-Kast). clinicaltrials.gov/ct2/show/NCT01542723 (first received 2 March 2012). vanAdrichemRA , NemethB , AlgraA , le CessieS , RosendaalFR , SchipperIB , et al. Thromboprophylaxis after knee arthroscopy and lower-leg casting. New England Journal of Medicine2017;376(6):515-25. ">van Adrichem 2017</a>), with one case in each treatment arm (RR 0.98, 95% CI 0.06 to 15.72; 1451 participants; moderateâcertainty evidence;Â <a href="./references#CD005259-fig-0008" title="">Analysis 1.5</a>). We downgraded the certainty of the evidence by one level for imprecision. </p> </section> <section id="CD005259-sec-0058"> <h5 class="title">Minor bleeding</h5> <p>All five studies assessed minor bleeding (<a href="./references#CD005259-bbs2-0003" title="CanataGL , ChieyA . Prevention of venous thromboembolism after ACL reconstruction: a prospective, randomized study. ISAKOS (International Society of Arthroscopy, Knee Surgery and Orthopaedic Sports Medicine)2003;Poster 71-2003. ">Canata 2003</a>;Â <a href="./references#CD005259-bbs2-0005" title="MichotM , ConenD , HoltzD , ErniD , ZumsteinMD , RuflinGB , et al. Prevention of deep-vein thrombosis in ambulatory arthroscopic knee surgery: a randomized trial of prophylaxis with low-molecular weight heparin. Arthroscopy2002;18(3):257-63. ">Michot 2002</a>;Â <a href="./references#CD005259-bbs2-0006" title="RothP . Prophylaxis of deep vein thrombosis in outpatients undergoing arthroscopic meniscus operation [Thromboembolieprophylaxe bei ambulant durchgefÃ¼rten arthroskopischen Meniskusoperationen]. OrthopÃ¤dische Praxis1995;5:345-8. ">Roth 1995</a>;Â <a href="./references#CD005259-bbs2-0007" title="NCT01542723. Pot-Kast: Thrombosis Prophylaxis After Knee Arthroscopy (Pot-Kast). clinicaltrials.gov/ct2/show/NCT01542723 (first received 2 March 2012). vanAdrichemRA , NemethB , AlgraA , le CessieS , RosendaalFR , SchipperIB , et al. Thromboprophylaxis after knee arthroscopy and lower-leg casting. New England Journal of Medicine2017;376(6):515-25. ">van Adrichem 2017</a>;Â <a href="./references#CD005259-bbs2-0008" title="WirthT , SchneiderB , MisselwitzF , LombM , TÃ¼ylÃ¼H , EgbringR , et al. Prevention of venous thromboembolism after knee arthroscopy with low-molecular weight heparin (Reviparin): results of a randomized controlled trial. Arthroscopy2001;17(4):393-9. ">Wirth 2001</a>). There was no clear difference in minor bleeding events with LMWH versus no prophylaxis (RR 1.79, 95% CI 0.84 to 3.84; 5 studies, 1978 participants; moderateâcertainty evidence;Â <a href="./references#CD005259-fig-0009" title="">Analysis 1.6</a>). We downgraded the certainty of the evidence by one level for imprecision. </p> <p>AsÂ <a href="./references#CD005259-bbs2-0007" title="NCT01542723. Pot-Kast: Thrombosis Prophylaxis After Knee Arthroscopy (Pot-Kast). clinicaltrials.gov/ct2/show/NCT01542723 (first received 2 March 2012). vanAdrichemRA , NemethB , AlgraA , le CessieS , RosendaalFR , SchipperIB , et al. Thromboprophylaxis after knee arthroscopy and lower-leg casting. New England Journal of Medicine2017;376(6):515-25. ">van Adrichem 2017</a>Â presented both PP and ITT data, we carried out a sensitivity analysis to investigate both datasets. There were no differences in the results, and we included the ITT data in our analysis. </p> </section> </section> <section id="CD005259-sec-0059"> <h4 class="title">Rivaroxaban versus placebo</h4> <section id="CD005259-sec-0060"> <h5 class="title">Pulmonary embolism</h5> <p>In the single study (234 participants) comparing rivaroxaban to placebo, there were no PE events during the study period (<a href="./references#CD005259-bbs2-0002" title="CamporeseG , BernardiE , NoventaF , BoscoM , BortoluzzC , MazzolaC , et al. Efficacy of rivaroxaban for prevention of venous thromboembolism after knee arthroscopy. a randomized double-blind trial (Erika study). International Angiology2014;33(Suppl 1):35. CamporeseG , BernardiE , NoventaF , BoscoM , MonteleoneG , SantoroL , et al. Efficacy of Rivaroxaban for thromboprophylaxis after Knee Arthroscopy (ERIKA). A phase II, multicentre, double-blind, placebo-controlled randomised study. Thrombosis and Haemostasis2016;116(2):349-55. CamporeseG , BernardiE , NoventaF . Efficacy of rivaroxaban for prevention of venous thromboembolism after knee arthroscopy: a randomized double-blind trial (ERIKA study). Journal of thrombosis and haemostasis2015;13:204. ">Camporese 2016</a>). </p> </section> <section id="CD005259-sec-0061"> <h5 class="title">Symptomatic deep vein thrombosis</h5> <p>There was no clear difference in the risk of symptomatic DVT with oral rivaroxaban 10 mg compared to placebo (RR 0.16, 95% CI 0.02 to 1.29; 234 participants; moderateâcertainty evidence;Â <a href="./references#CD005259-fig-0010" title="">Analysis 2.1</a>). We downgraded the certainty of the evidence by one level for imprecision of the estimate. </p> </section> <section id="CD005259-sec-0062"> <h5 class="title">Asymptomatic deep vein thrombosis</h5> <p>There was no clear difference in the risk of asymptomatic DVT, as diagnosed by compression ultrasonography, with oral rivaroxaban 10 mg compared to placebo (RR 0.95, 95% CI 0.06 to 15.01; 234 participants; very lowâcertainty evidence;Â <a href="./references#CD005259-fig-0011" title="">Analysis 2.2</a>). We downgraded the certainty of the evidence by three levels for imprecision, risk of bias and indirectness of the outcome. </p> </section> <section id="CD005259-sec-0063"> <h5 class="title">Allâcause mortality</h5> <p>No deaths occurred in either group.</p> </section> <section id="CD005259-sec-0064"> <h5 class="title">All reported adverse effects (pain, allergies, minor and major bleeding)</h5> <p><a href="./references#CD005259-bbs2-0002" title="CamporeseG , BernardiE , NoventaF , BoscoM , BortoluzzC , MazzolaC , et al. Efficacy of rivaroxaban for prevention of venous thromboembolism after knee arthroscopy. a randomized double-blind trial (Erika study). International Angiology2014;33(Suppl 1):35. CamporeseG , BernardiE , NoventaF , BoscoM , MonteleoneG , SantoroL , et al. Efficacy of Rivaroxaban for thromboprophylaxis after Knee Arthroscopy (ERIKA). A phase II, multicentre, double-blind, placebo-controlled randomised study. Thrombosis and Haemostasis2016;116(2):349-55. CamporeseG , BernardiE , NoventaF . Efficacy of rivaroxaban for prevention of venous thromboembolism after knee arthroscopy: a randomized double-blind trial (ERIKA study). Journal of thrombosis and haemostasis2015;13:204. ">Camporese 2016</a>Â did not assess any adverse effects other than major and minor bleeding, which are reported below. </p> </section> <section id="CD005259-sec-0065"> <h5 class="title">Major bleeding</h5> <p>No major bleeding events occurred.</p> </section> <section id="CD005259-sec-0066"> <h5 class="title">Minor bleeding</h5> <p>There was no clear difference in the risk of minor bleeding with rivaroxaban compared to placebo (RR 0.63, 95% CI 0.18 to 2.19; 234 participants; moderateâcertainty evidence;Â <a href="./references#CD005259-fig-0012" title="">Analysis 2.3</a>). We downgraded the certainty of the evidence by one level for the imprecision of the estimate. </p> </section> </section> <section id="CD005259-sec-0067"> <h4 class="title">Aspirin versus no prophylaxis</h4> <section id="CD005259-sec-0068"> <h5 class="title">Pulmonary embolism</h5> <p>In the single study comparing aspirin to no prophylaxis, no PE events occurred during the study period (<a href="./references#CD005259-bbs2-0004" title="KayeID , PatelDN , StraussEJ , AlaiaMJ , GarofoloG , MartinezA , et al. Prevention of venous thromboembolism after arthroscopic knee surgery in a low-risk population with the use of aspirin. A randomized trial. Bulletin of the Hospital for Joint Diseases2015;73(4):234-8. ">Kaye 2015</a>). </p> </section> <section id="CD005259-sec-0069"> <h5 class="title">Symptomatic deep vein thrombosis</h5> <p>No symptomatic DVT events occurred.</p> </section> <section id="CD005259-sec-0070"> <h5 class="title">Asymptomatic deep vein thrombosis</h5> <p>No asymptomatic DVT events occurred. Asymptomatic events were investigated using compression ultrasonography. </p> </section> <section id="CD005259-sec-0071"> <h5 class="title">Allâcause mortality</h5> <p>No deaths occurred.</p> </section> <section id="CD005259-sec-0072"> <h5 class="title">All reported adverse effects (pain, allergies, minor and major bleeding)</h5> <p><a href="./references#CD005259-bbs2-0004" title="KayeID , PatelDN , StraussEJ , AlaiaMJ , GarofoloG , MartinezA , et al. Prevention of venous thromboembolism after arthroscopic knee surgery in a low-risk population with the use of aspirin. A randomized trial. Bulletin of the Hospital for Joint Diseases2015;73(4):234-8. ">Kaye 2015</a>Â reported complications including pain and swelling (15 cases, 9%) and residual joint line tenderness (5 cases, 3%), but did not specify which groups they occurred in. Three participants developed knee swelling. Two of these participants were randomized to the aspirin group. </p> </section> <section id="CD005259-sec-0073"> <h5 class="title">Major bleeding</h5> <p>No major bleeding events occurred.</p> </section> <section id="CD005259-sec-0074"> <h5 class="title">Minor bleeding</h5> <p>No minor bleeding events occurred.</p> </section> </section> <section id="CD005259-sec-0075"> <h4 class="title">Lowâmolecularâweight heparin versus compression stockings</h4> <section id="CD005259-sec-0076"> <h5 class="title">Pulmonary embolism</h5> <p>In the single study comparing LMWH to compression stockings, there was no clear difference in the risk of PE between the groups (RR 1.00, 95% CI 0.14 to 7.05; 1317 participants; lowâcertainty evidence;Â <a href="./references#CD005259-fig-0013" title="">Analysis 3.1</a>;Â <a href="./references#CD005259-bbs2-0001" title="CamporeseG , BernardiE , N'TitaK , VerlatoF , SalmistraroG , CordovaR , et al. Different thromboprophylaxis approaches in patients undergoing knee arthroscopy (KANT Study): a prospective randomized study. Journal of Thrombosis and Haemostasis2005;3(1):Abstract number: P1618. CamporeseG , BernardiE , PrandoniP , NoventaF , VerlatoF , CordovaR , et al. Graduated compression stockings versus low molecular- weight heparin for prevention of deep vein thrombosis after knee arthroscopy: a randomized trial. Pathophysiology of Haemostasis and Thrombosis2008;36(Suppl 1):A21. CamporeseG , BernardiE , PrandoniP , NoventaF , VerlatoF , SimioniP , et al. Low-molecular-weight heparin versus compression stockings for thromboprophylaxis after knee arthroscopy: a randomized trial. Annals of Internal Medicine2008;149(2):73-82. CamporeseG , N'TitaK , RossiF , BernardiE , VerlatoF , SalmistraroG , et al. Different thromboprophylaxis approaches in patients undergoing knee arthroscopy (KANT study): interim report of prospective randomized study. Journal of Thrombosis and Haemostasis2003;1(Suppl 1):Abstract P1888. ">Camporese 2008</a>). We downgraded the certainty of the evidence by two levels for imprecision due to the low number of events and for risk of bias concerns. </p> </section> <section id="CD005259-sec-0077"> <h5 class="title">Symptomatic deep vein thrombosis</h5> <p>LMWH resulted in a lower risk of symptomatic DVT compared to compression stockings (RR 0.17, 95% CI 0.04 to 0.75; 1317 participants; lowâcertainty evidence;Â <a href="./references#CD005259-fig-0014" title="">Analysis 3.2</a>). We downgraded the certainty of the evidence by two levels for imprecision of the absolute effects and for risk of bias. </p> </section> <section id="CD005259-sec-0078"> <h5 class="title">Asymptomatic deep vein thrombosis</h5> <p>There was no clear difference in the risk of asymptomatic DVT, as diagnosed by compression ultrasonography, with LMWH compared to compression stockings (RR 0.47, 95% CI 0.21 to 1.09; 1317 participants; very lowâcertainty evidence;Â <a href="./references#CD005259-fig-0015" title="">Analysis 3.3</a>). We downgraded the certainty of the evidence by three levels for imprecision of the estimates due to the low number of events, for indirectness and for risk of bias concerns. </p> </section> <section id="CD005259-sec-0079"> <h5 class="title">Mortality</h5> <p>No deaths occurred in either group.</p> </section> <section id="CD005259-sec-0080"> <h5 class="title">All reported adverse effects (pain, allergies, minor bleeding and major bleeding)</h5> <p>In addition to major bleeding and minor bleeding,Â <a href="./references#CD005259-bbs2-0001" title="CamporeseG , BernardiE , N'TitaK , VerlatoF , SalmistraroG , CordovaR , et al. Different thromboprophylaxis approaches in patients undergoing knee arthroscopy (KANT Study): a prospective randomized study. Journal of Thrombosis and Haemostasis2005;3(1):Abstract number: P1618. CamporeseG , BernardiE , PrandoniP , NoventaF , VerlatoF , CordovaR , et al. Graduated compression stockings versus low molecular- weight heparin for prevention of deep vein thrombosis after knee arthroscopy: a randomized trial. Pathophysiology of Haemostasis and Thrombosis2008;36(Suppl 1):A21. CamporeseG , BernardiE , PrandoniP , NoventaF , VerlatoF , SimioniP , et al. Low-molecular-weight heparin versus compression stockings for thromboprophylaxis after knee arthroscopy: a randomized trial. Annals of Internal Medicine2008;149(2):73-82. CamporeseG , N'TitaK , RossiF , BernardiE , VerlatoF , SalmistraroG , et al. Different thromboprophylaxis approaches in patients undergoing knee arthroscopy (KANT study): interim report of prospective randomized study. Journal of Thrombosis and Haemostasis2003;1(Suppl 1):Abstract P1888. ">Camporese 2008</a>Â reported pain, tenderness, and edema. The study showed no clear difference between the groups (RR 1.17, 95% CI 0.95 to 1.43; 1317 participants; moderateâcertainty evidence;Â <a href="./references#CD005259-fig-0016" title="">Analysis 3.4</a>). We downgraded the certainty of the evidence by one level for imprecision due to the small number of events and small sample size. In the compression stockings group, 152 participants reported symptoms (pain, 92; tenderness, 23; edema, 24; discoloration, 10; and nonvaricose collateral symptoms, 3), compared with 131 participants in the LMWH group (pain, 85; tenderness, 18; edema, 18; discoloration, 8; and nonvaricose collateral symptoms, 2). Thrombocytopenia was not assessed. </p> </section> <section id="CD005259-sec-0081"> <h5 class="title">Major bleeding</h5> <p>There was no clear difference between the groups for major bleeding (RR 3.01, 95% CI 0.61 to 14.88; 1317 participants; moderateâcertainty evidence;Â <a href="./references#CD005259-fig-0016" title="">Analysis 3.4</a>). We downgraded the certainty of the evidence by one level for imprecision due to the small sample size and small number of events. </p> </section> <section id="CD005259-sec-0082"> <h5 class="title">Minor bleeding</h5> <p>There was no clear difference between the groups for minor bleeding (RR 1.16, 95% CI 0.64 to 2.08; 1317 participants; moderateâcertainty evidence;Â <a href="./references#CD005259-fig-0016" title="">Analysis 3.4</a>). We downgraded the certainty of the evidence by one level for imprecision due to the small sample size and small number of events. </p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD005259-sec-0083" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD005259-sec-0083"></div> <section id="CD005259-sec-0084"> <h3 class="title" id="CD005259-sec-0084">Summary of main results</h3> <p>LMWH probably leads to little or no difference in PE when compared to no prophylaxis (moderateâcertainty evidence) and may lead to little or no difference when compared with stockings (lowâcertainty evidence). There were no PE events reported for aspirin and rivaroxaban. The overall risk of PE was low, with 7 cases in 3499 participants (less than 0.2%), evenly distributed between intervention and control groups. There were no deaths due to PE or any other cause in any of the included studies. </p> <p>LMWH may lead to little or no difference in the risk of symptomatic DVT (people presenting with symptoms of DVT at the emergency department, or symptoms with a positive screening) compared to no prophylaxis (lowâcertainty evidence). Rivaroxaban probably leads to little or no difference in symptomatic DVT (moderateâcertainty evidence). Compared with compression stockings, LMWH may lead to a reduced rate of DVT (lowâcertainty evidence). </p> <p>It is unclear whether LMWH, compression, or rivaroxaban reduce the risk of asymptomatic DVT because the certainty of the evidence is very low. No asymptomatic DVT events were detected in the study investigating aspirin versus no prophylaxis. </p> <p>There is probably little or no difference in adverse effects for any comparison (moderateâcertainty evidence), but results were limited by low numbers of studies reporting clearly on this outcome. When reported, there was probably little or no difference in the rates of major or minor bleeding (moderateâcertainty evidence). </p> <p>In conclusion, there is moderate to lowâcertainty evidence of little or no difference with the use of LMWH, aspirin or rivaroxaban compared to placebo or no prophylaxis for the risk of PE or symptomatic DVT in lowârisk adults undergoing KA. </p> </section> <section id="CD005259-sec-0085"> <h3 class="title" id="CD005259-sec-0085">Overall completeness and applicability of evidence</h3> <p>This evidence is applicable to otherwise healthy adults, at low risk of DVT, undergoing KA for minor conditions. Study participants had no history of any thromboembolic events, were not pregnant, had no history of any coagulation disorder that would put them at risk of thromboembolic events, and had accessible health care systems. People taking birth control pills were excluded in only one study. </p> <p>The population included participants who smoked or were obese, with similar numbers of each in the intervention and control groups. We were unable to perform subgroup analyses according to these variables owing to the low rate of events, but study authors did not report more events in participants with these characteristics. </p> <p>A major limitation in all the studies is the low event rate for severe thromboembolic events (symptomatic DVT or PE). The event rate was similar to that reported in observational studies. This confirms that KA in healthy individuals carries a small risk of symptomatic thrombosis, but it also makes it difficult to detect any benefit from the proposed interventions. Interestingly, the incidence of symptomatic DVT was higher in the compression stocking group of theÂ <a href="./references#CD005259-bbs2-0001" title="CamporeseG , BernardiE , N'TitaK , VerlatoF , SalmistraroG , CordovaR , et al. Different thromboprophylaxis approaches in patients undergoing knee arthroscopy (KANT Study): a prospective randomized study. Journal of Thrombosis and Haemostasis2005;3(1):Abstract number: P1618. CamporeseG , BernardiE , PrandoniP , NoventaF , VerlatoF , CordovaR , et al. Graduated compression stockings versus low molecular- weight heparin for prevention of deep vein thrombosis after knee arthroscopy: a randomized trial. Pathophysiology of Haemostasis and Thrombosis2008;36(Suppl 1):A21. CamporeseG , BernardiE , PrandoniP , NoventaF , VerlatoF , SimioniP , et al. Low-molecular-weight heparin versus compression stockings for thromboprophylaxis after knee arthroscopy: a randomized trial. Annals of Internal Medicine2008;149(2):73-82. CamporeseG , N'TitaK , RossiF , BernardiE , VerlatoF , SalmistraroG , et al. Different thromboprophylaxis approaches in patients undergoing knee arthroscopy (KANT study): interim report of prospective randomized study. Journal of Thrombosis and Haemostasis2003;1(Suppl 1):Abstract P1888. ">Camporese 2008</a>Â study than in any other arm across all included studies in this review. This group had a 2% incidence of symptomatic DVT while the literature reports rates below 0.5% (<a href="./references#CD005259-bbs2-0026" title="MaletisG , InacioM , ReynoldsS , FunahshiT . Incidence of symptomatic venous thromboembolism after elective knee arthroscopy. Journal of Bone and Joint Surgery2012;94:714-20.">Maletis 2012</a>). </p> <p>Only one study reflected a 'real life' scenario (<a href="./references#CD005259-bbs2-0007" title="NCT01542723. Pot-Kast: Thrombosis Prophylaxis After Knee Arthroscopy (Pot-Kast). clinicaltrials.gov/ct2/show/NCT01542723 (first received 2 March 2012). vanAdrichemRA , NemethB , AlgraA , le CessieS , RosendaalFR , SchipperIB , et al. Thromboprophylaxis after knee arthroscopy and lower-leg casting. New England Journal of Medicine2017;376(6):515-25. ">van Adrichem 2017</a>): rather than actively looking for thromboembolic events, the study authors identified participants who had attended an emergency department or had been admitted for PE or DVT. PE and symptomatic DVT data were obtained from hospital registries up to three months after the procedure. It is possible but unlikely that the study authors missed significant events with this approach. In any case, it reflects what occurs in daily practice within a healthcare system that has good accessibility. </p> <p>It is possible that in healthcare systems with poor accessibility or that are highly fragmented, thromboembolic events may be missed. As there is still a risk â however small â for thromboembolic events following KA, the healthcare team looking after these people (general practitioners, orthopedic surgeons, physiotherapists, emergency department team) need to advise them to seek medical care if any thromboembolic symptoms develop. </p> <p>The evidence presented in this review may not be applicable to people who are at higher risk of PE or DVT, who are unable to reach their surgeons or do not have access to healthcare, or who are unable to achieve early mobility after the procedure. </p> </section> <section id="CD005259-sec-0086"> <h3 class="title" id="CD005259-sec-0086">Quality of the evidence</h3> <p>The certainty of the evidence is moderate to low for the outcomes PE, symptomatic DVT and adverse effects (including major and minor bleeding). The certainty of the evidence for asymptomatic DVT is very low. Outcomes were more prone to bias in cases where interventions were not blinded. Those who assessed outcomes were blinded to the allocated treatment arm, provided the participants did not break this blinding (e.g. by revealing the injection site). We downgraded for risk of bias concerns when we felt this could have impacted outcome assessment. </p> <p>There was significant imprecision in all the clinical outcomes, mostly due to the low rate of symptomatic thromboembolic events after KA in lowârisk participants. It is possible that larger sample sizes would provide different results. </p> <p>There is very lowâcertainty evidence that LMWH reduces the occurrence of asymptomatic DVT compared to no prophylaxis. The clinical significance of DVT diagnosed through an echoâDoppler or compression ultrasonography scan is uncertain in the context of KA in a healthy person, so we downgraded the certainty of the evidence for indirectness, as well as for imprecision and for risk of bias concerns. </p> <p>We created a summary of findings table for the comparison of LMWH versus no prophylaxis but not for the remaining comparisons, which were based on data from single studies. SeeÂ <a href="./full#CD005259-tbl-0001">summary of findings Table 1</a>. </p> </section> <section id="CD005259-sec-0087"> <h3 class="title" id="CD005259-sec-0087">Potential biases in the review process</h3> <p>We carried out a thorough search and are confident that we have assessed all relevant studies. However, the available evidence is limited by the small number of studies eligible for inclusion. We followed the procedures outlined in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD005259-bbs2-0021" title="HigginsJP , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1/.">Higgins 2011</a>), with review authors independently assessing studies of inclusion, extracting data and assessing risk of bias. </p> </section> <section id="CD005259-sec-0088"> <h3 class="title" id="CD005259-sec-0088">Agreements and disagreements with other studies or reviews</h3> <p>One systematic review investigating only LMWH reached similar conclusions to our review (<a href="./references#CD005259-bbs2-0022" title="HuangHF , Tian JL YangXT , SunL , HuRY , YanZH , et al. Efficacy and safety of low-molecular-weight heparin after knee arthroscopy: a meta-analysis. PLoS ONE2018;13(6):e0197868. [DOI: 10.1371/journal.pone.0197868]">Huang 2018</a>). We aimed to include all types of interventions to prevent DVT, including pharmacological and mechanical interventions. Compared withÂ <a href="./references#CD005259-bbs2-0022" title="HuangHF , Tian JL YangXT , SunL , HuRY , YanZH , et al. Efficacy and safety of low-molecular-weight heparin after knee arthroscopy: a meta-analysis. PLoS ONE2018;13(6):e0197868. [DOI: 10.1371/journal.pone.0197868]">Huang 2018</a>, our review also included studies using aspirin and rivaroxaban as pharmacological interventions (<a href="./references#CD005259-bbs2-0002" title="CamporeseG , BernardiE , NoventaF , BoscoM , BortoluzzC , MazzolaC , et al. Efficacy of rivaroxaban for prevention of venous thromboembolism after knee arthroscopy. a randomized double-blind trial (Erika study). International Angiology2014;33(Suppl 1):35. CamporeseG , BernardiE , NoventaF , BoscoM , MonteleoneG , SantoroL , et al. Efficacy of Rivaroxaban for thromboprophylaxis after Knee Arthroscopy (ERIKA). A phase II, multicentre, double-blind, placebo-controlled randomised study. Thrombosis and Haemostasis2016;116(2):349-55. CamporeseG , BernardiE , NoventaF . Efficacy of rivaroxaban for prevention of venous thromboembolism after knee arthroscopy: a randomized double-blind trial (ERIKA study). Journal of thrombosis and haemostasis2015;13:204. ">Camporese 2016</a>;Â <a href="./references#CD005259-bbs2-0004" title="KayeID , PatelDN , StraussEJ , AlaiaMJ , GarofoloG , MartinezA , et al. Prevention of venous thromboembolism after arthroscopic knee surgery in a low-risk population with the use of aspirin. A randomized trial. Bulletin of the Hospital for Joint Diseases2015;73(4):234-8. ">Kaye 2015</a>). Of note,Â <a href="./references#CD005259-bbs2-0022" title="HuangHF , Tian JL YangXT , SunL , HuRY , YanZH , et al. Efficacy and safety of low-molecular-weight heparin after knee arthroscopy: a meta-analysis. PLoS ONE2018;13(6):e0197868. [DOI: 10.1371/journal.pone.0197868]">Huang 2018</a>Â includedÂ <a href="./references#CD005259-bbs2-0009" title="MarlovitsS , StriessnigG , SchusterR , StockerR , LuxlM , TrattnigR , et al. A prospective, randomized, placebo-controlled study of extended-duration post-discharge thromboprophylaxis with enoxaparin following arthroscopic reconstruction of the anterior cruciate ligament. Blood2004;104(11 Part 1):Abstract 1764. MarlovitsS , StriessnigG , SchusterR , StockerR , LuxlM , TrattnigS , et al. Extended-duration thromboprophylaxis with enoxaparin after arthroscopic surgery of the anterior cruciate ligament: a prospective, randomized, placebo-controlled study. Arthroscopy2007;23(7):696-702. ">Marlovits 2004</a>, which we excluded because it compared shortâduration LMWH with extendedâduration LMWH.Â <a href="./references#CD005259-bbs2-0022" title="HuangHF , Tian JL YangXT , SunL , HuRY , YanZH , et al. Efficacy and safety of low-molecular-weight heparin after knee arthroscopy: a meta-analysis. PLoS ONE2018;13(6):e0197868. [DOI: 10.1371/journal.pone.0197868]">Huang 2018</a>Â also excluded distal DVT from their analysis. One network metaâanalysis agreed with our findings of no difference between interventions to reduce thrombosis after KA (<a href="./references#CD005259-bbs2-0024" title="LameireDL , KhalikHA , PhillipsM , MacDonaldAE , BanfieldL , deSaD , et al. Thromboprophylaxis after knee arthroscopy does not decrease the risk of deep vein thrombosis: a network meta-analysis. Knee Surgery, Sports Traumatology, Arthroscopy2022;3:1-3. [PMID: 10.1007/s00167-021-06857-5.]">Lameire 2022</a>). </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD005259-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005259.pub5/media/CDSR/CD005259/urn:x-wiley:14651858:media:CD005259:CD005259-FIG-01" target="_blank"><b></b></a></p> </div><img alt="Flow diagram" data-id="CD005259-fig-0001" src="/cdsr/doi/10.1002/14651858.CD005259.pub5/media/CDSR/CD005259/image_n/nCD005259-FIG-01.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005259.pub5/media/CDSR/CD005259/image_t/tCD005259-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Flow diagram</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005259.pub5/full#CD005259-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005259.pub5/media/CDSR/CD005259/image_n/nCD005259-FIG-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005259-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005259.pub5/media/CDSR/CD005259/urn:x-wiley:14651858:media:CD005259:CD005259-FIG-02" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgments about each risk of bias item presented as percentages across all included studies." data-id="CD005259-fig-0002" src="/cdsr/doi/10.1002/14651858.CD005259.pub5/media/CDSR/CD005259/image_n/nCD005259-FIG-02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005259.pub5/media/CDSR/CD005259/image_t/tCD005259-FIG-02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgments about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005259.pub5/full#CD005259-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005259.pub5/media/CDSR/CD005259/image_n/nCD005259-FIG-02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005259-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005259.pub5/media/CDSR/CD005259/urn:x-wiley:14651858:media:CD005259:CD005259-FIG-03" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgments about each risk of bias item for each included study." data-id="CD005259-fig-0003" src="/cdsr/doi/10.1002/14651858.CD005259.pub5/media/CDSR/CD005259/image_n/nCD005259-FIG-03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005259.pub5/media/CDSR/CD005259/image_t/tCD005259-FIG-03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgments about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005259.pub5/full#CD005259-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005259.pub5/media/CDSR/CD005259/image_n/nCD005259-FIG-03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005259-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005259.pub5/media/CDSR/CD005259/urn:x-wiley:14651858:media:CD005259:CD005259-CMP-001.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Lowâmolecularâweight heparin (LMWH) versus no prophylaxis, Outcome 1: Pulmonary embolism" data-id="CD005259-fig-0004" src="/cdsr/doi/10.1002/14651858.CD005259.pub5/media/CDSR/CD005259/image_n/nCD005259-CMP-001.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005259.pub5/media/CDSR/CD005259/image_t/tCD005259-CMP-001.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1: Lowâmolecularâweight heparin (LMWH) versus no prophylaxis, Outcome 1: Pulmonary embolism </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005259.pub5/references#CD005259-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005259.pub5/media/CDSR/CD005259/image_n/nCD005259-CMP-001.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005259-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005259.pub5/media/CDSR/CD005259/urn:x-wiley:14651858:media:CD005259:CD005259-CMP-001.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Lowâmolecularâweight heparin (LMWH) versus no prophylaxis, Outcome 2: Symptomatic deep vein thrombosis" data-id="CD005259-fig-0005" src="/cdsr/doi/10.1002/14651858.CD005259.pub5/media/CDSR/CD005259/image_n/nCD005259-CMP-001.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005259.pub5/media/CDSR/CD005259/image_t/tCD005259-CMP-001.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1: Lowâmolecularâweight heparin (LMWH) versus no prophylaxis, Outcome 2: Symptomatic deep vein thrombosis </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005259.pub5/references#CD005259-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005259.pub5/media/CDSR/CD005259/image_n/nCD005259-CMP-001.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005259-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005259.pub5/media/CDSR/CD005259/urn:x-wiley:14651858:media:CD005259:CD005259-CMP-001.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Lowâmolecularâweight heparin (LMWH) versus no prophylaxis, Outcome 3: Asymptomatic deep vein thrombosis" data-id="CD005259-fig-0006" src="/cdsr/doi/10.1002/14651858.CD005259.pub5/media/CDSR/CD005259/image_n/nCD005259-CMP-001.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005259.pub5/media/CDSR/CD005259/image_t/tCD005259-CMP-001.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1: Lowâmolecularâweight heparin (LMWH) versus no prophylaxis, Outcome 3: Asymptomatic deep vein thrombosis </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005259.pub5/references#CD005259-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005259.pub5/media/CDSR/CD005259/image_n/nCD005259-CMP-001.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005259-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005259.pub5/media/CDSR/CD005259/urn:x-wiley:14651858:media:CD005259:CD005259-CMP-001.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Lowâmolecularâweight heparin (LMWH) versus no prophylaxis, Outcome 4: Adverse effects" data-id="CD005259-fig-0007" src="/cdsr/doi/10.1002/14651858.CD005259.pub5/media/CDSR/CD005259/image_n/nCD005259-CMP-001.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005259.pub5/media/CDSR/CD005259/image_t/tCD005259-CMP-001.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1: Lowâmolecularâweight heparin (LMWH) versus no prophylaxis, Outcome 4: Adverse effects </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005259.pub5/references#CD005259-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005259.pub5/media/CDSR/CD005259/image_n/nCD005259-CMP-001.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005259-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005259.pub5/media/CDSR/CD005259/urn:x-wiley:14651858:media:CD005259:CD005259-CMP-001.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Lowâmolecularâweight heparin (LMWH) versus no prophylaxis, Outcome 5: Major bleeding" data-id="CD005259-fig-0008" src="/cdsr/doi/10.1002/14651858.CD005259.pub5/media/CDSR/CD005259/image_n/nCD005259-CMP-001.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005259.pub5/media/CDSR/CD005259/image_t/tCD005259-CMP-001.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1: Lowâmolecularâweight heparin (LMWH) versus no prophylaxis, Outcome 5: Major bleeding </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005259.pub5/references#CD005259-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005259.pub5/media/CDSR/CD005259/image_n/nCD005259-CMP-001.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005259-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005259.pub5/media/CDSR/CD005259/urn:x-wiley:14651858:media:CD005259:CD005259-CMP-001.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Lowâmolecularâweight heparin (LMWH) versus no prophylaxis, Outcome 6: Minor bleeding" data-id="CD005259-fig-0009" src="/cdsr/doi/10.1002/14651858.CD005259.pub5/media/CDSR/CD005259/image_n/nCD005259-CMP-001.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005259.pub5/media/CDSR/CD005259/image_t/tCD005259-CMP-001.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1: Lowâmolecularâweight heparin (LMWH) versus no prophylaxis, Outcome 6: Minor bleeding </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005259.pub5/references#CD005259-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005259.pub5/media/CDSR/CD005259/image_n/nCD005259-CMP-001.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005259-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005259.pub5/media/CDSR/CD005259/urn:x-wiley:14651858:media:CD005259:CD005259-CMP-002.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Rivaroxaban versus placebo, Outcome 1: Symptomatic deep vein thrombosis" data-id="CD005259-fig-0010" src="/cdsr/doi/10.1002/14651858.CD005259.pub5/media/CDSR/CD005259/image_n/nCD005259-CMP-002.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005259.pub5/media/CDSR/CD005259/image_t/tCD005259-CMP-002.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2: Rivaroxaban versus placebo, Outcome 1: Symptomatic deep vein thrombosis</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005259.pub5/references#CD005259-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005259.pub5/media/CDSR/CD005259/image_n/nCD005259-CMP-002.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005259-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005259.pub5/media/CDSR/CD005259/urn:x-wiley:14651858:media:CD005259:CD005259-CMP-002.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Rivaroxaban versus placebo, Outcome 2: Asymptomatic deep vein thrombosis" data-id="CD005259-fig-0011" src="/cdsr/doi/10.1002/14651858.CD005259.pub5/media/CDSR/CD005259/image_n/nCD005259-CMP-002.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005259.pub5/media/CDSR/CD005259/image_t/tCD005259-CMP-002.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2: Rivaroxaban versus placebo, Outcome 2: Asymptomatic deep vein thrombosis</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005259.pub5/references#CD005259-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005259.pub5/media/CDSR/CD005259/image_n/nCD005259-CMP-002.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005259-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005259.pub5/media/CDSR/CD005259/urn:x-wiley:14651858:media:CD005259:CD005259-CMP-002.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Rivaroxaban versus placebo, Outcome 3: Minor bleeding" data-id="CD005259-fig-0012" src="/cdsr/doi/10.1002/14651858.CD005259.pub5/media/CDSR/CD005259/image_n/nCD005259-CMP-002.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005259.pub5/media/CDSR/CD005259/image_t/tCD005259-CMP-002.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2: Rivaroxaban versus placebo, Outcome 3: Minor bleeding</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005259.pub5/references#CD005259-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005259.pub5/media/CDSR/CD005259/image_n/nCD005259-CMP-002.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005259-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005259.pub5/media/CDSR/CD005259/urn:x-wiley:14651858:media:CD005259:CD005259-CMP-003.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Lowâmolecularâweight heparin (LMWH) versus compression stockings, Outcome 1: Pulmonary embolism" data-id="CD005259-fig-0013" src="/cdsr/doi/10.1002/14651858.CD005259.pub5/media/CDSR/CD005259/image_n/nCD005259-CMP-003.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005259.pub5/media/CDSR/CD005259/image_t/tCD005259-CMP-003.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3: Lowâmolecularâweight heparin (LMWH) versus compression stockings, Outcome 1: Pulmonary embolism </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005259.pub5/references#CD005259-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005259.pub5/media/CDSR/CD005259/image_n/nCD005259-CMP-003.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005259-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005259.pub5/media/CDSR/CD005259/urn:x-wiley:14651858:media:CD005259:CD005259-CMP-003.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Lowâmolecularâweight heparin (LMWH) versus compression stockings, Outcome 2: Symptomatic deep vein thrombosis" data-id="CD005259-fig-0014" src="/cdsr/doi/10.1002/14651858.CD005259.pub5/media/CDSR/CD005259/image_n/nCD005259-CMP-003.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005259.pub5/media/CDSR/CD005259/image_t/tCD005259-CMP-003.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3: Lowâmolecularâweight heparin (LMWH) versus compression stockings, Outcome 2: Symptomatic deep vein thrombosis </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005259.pub5/references#CD005259-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005259.pub5/media/CDSR/CD005259/image_n/nCD005259-CMP-003.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005259-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005259.pub5/media/CDSR/CD005259/urn:x-wiley:14651858:media:CD005259:CD005259-CMP-003.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Lowâmolecularâweight heparin (LMWH) versus compression stockings, Outcome 3: Asymptomatic deep vein thrombosis" data-id="CD005259-fig-0015" src="/cdsr/doi/10.1002/14651858.CD005259.pub5/media/CDSR/CD005259/image_n/nCD005259-CMP-003.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005259.pub5/media/CDSR/CD005259/image_t/tCD005259-CMP-003.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3: Lowâmolecularâweight heparin (LMWH) versus compression stockings, Outcome 3: Asymptomatic deep vein thrombosis </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005259.pub5/references#CD005259-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005259.pub5/media/CDSR/CD005259/image_n/nCD005259-CMP-003.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005259-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005259.pub5/media/CDSR/CD005259/urn:x-wiley:14651858:media:CD005259:CD005259-CMP-003.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Lowâmolecularâweight heparin (LMWH) versus compression stockings, Outcome 4: Adverse effects" data-id="CD005259-fig-0016" src="/cdsr/doi/10.1002/14651858.CD005259.pub5/media/CDSR/CD005259/image_n/nCD005259-CMP-003.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005259.pub5/media/CDSR/CD005259/image_t/tCD005259-CMP-003.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3: Lowâmolecularâweight heparin (LMWH) versus compression stockings, Outcome 4: Adverse effects </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005259.pub5/references#CD005259-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005259.pub5/media/CDSR/CD005259/image_n/nCD005259-CMP-003.04.svg" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD005259-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span>Â <span class="table-title">Lowâmolecularâweight heparin compared to no prophylaxis for preventing venous thromboembolism in adults undergoing knee arthroscopy</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>LMWH compared to no prophylaxis for preventing VTE in adults undergoing KA</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> adults undergoing KA<br/><b>Setting:</b> hospital<br/><b>Intervention:</b> LMWH<br/><b>Comparison:</b> no prophylaxis </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Number of participants<br/>(RCTs)</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Interpretation</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Without LMWH</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>With LMWH</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>PE:</b> assessed by CT arteriography (followâup: 30 days to 3 months)<br/>Â  </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>1820<br/>(3 RCTs) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.81</b><br/>(0.49 to 6.65) </p> </td> <th align="" class="headercell" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Study population</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>ââââ<br/><b>Moderate</b><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>LMWH probably leads to little or no difference in rates of PE.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 per 1000 (2 to 22)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Symptomatic DVT:</b> assessed by presence of symptoms and confirmed by a positive compression ultrasound (followâup: 30 days to 3 months)<br/>Â  </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>1848<br/>(4 RCTs) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.61</b><br/>(0.18 to 2.03) </p> </td> <th align="" class="headercell" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Study population</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>ââââ<br/><b>Low</b><sup>b</sup> </p> <p>Â </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>LMWH may lead to little or no difference in symptomatic DVT.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7 per 1000 (2 to 22)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Asymptomatic DVT:</b> assessed with compression ultrasound (followâup: 30 days to 8 weeks) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>369<br/>(2 RCTs) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.14</b><br/>(0.03 to 0.61) </p> </td> <th align="" class="headercell" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Study population</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>ââââ<br/><b>Very low</b><sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>It is uncertain if LMWH reduces the risk asymptomatic DVT.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>81 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11 per 1000 (2 to 49)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Allâcause mortality</b> (followâup: 30 days to 3 months)<br/>Â  </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>1978<br/>(5 RCTs) </p> </td> <td align="" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No deaths occurred in any of the included studies.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>All adverse effects</b>, including allergies at injection site, minor and major bleeding, others (followâup: 30 days to 3 months)<br/>Â  </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>1978<br/>(5 RCTs) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.85</b><br/>(0.95 to 3.59) </p> </td> <th align="" class="headercell" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Study population</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>ââââ</p> <p><b>Moderate</b><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>LMWH probably leads to little or no difference in adverse effects.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24 per 1000<br/>(13 to 47) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Major bleeding</b> (followâup: 30 days to 3 months)<br/>Â  </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>1451<br/>(1 RCT) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.98</b> </p> <p>(0.06 to 15.72).</p> </td> <th align="" class="headercell" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Study population</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>ââââ<br/><b>Moderate</b><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>LMWH probably leads to little or no difference in rates of major bleeding.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 per 1000</p> <p>(0 to 22)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Minor bleeding</b> (followâup: 30 days to 3 months) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>1978<br/>(5 RCTs) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.79</b><br/>(0.84 to 3.84) </p> </td> <th align="" class="headercell" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Study population</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>ââââ<br/><b>Moderate</b><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>LMWH probably leads to little or no difference in rates of minor bleeding.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20 per 1000 (9 to 43)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> confidence interval; <b>CT:</b> computed tomography; <b>DVT:</b> deep vein thrombosis;<b>KA:</b> knee arthroscopy; <b>LMWH:</b> lowâmolecularâweight heparin; <b>PE:</b> pulmonary embolism; <b>RCT:</b> randomized controlled trial; <b>RR:</b> risk ratio; <b>VTE:</b> venous thromboembolism. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level for imprecision.<br/><sup>b</sup>Downgraded two levels for imprecision and risk of bias.<br/><sup>c</sup>Downgraded three levels for imprecision, risk of bias, and indirectness. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span>Â <span class="table-title">Lowâmolecularâweight heparin compared to no prophylaxis for preventing venous thromboembolism in adults undergoing knee arthroscopy</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005259.pub5/full#CD005259-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD005259-tbl-0002"> <div class="table-heading"><span class="table-label">Comparison 1.</span>Â <span class="table-title">Lowâmolecularâweight heparin (LMWH) versus no prophylaxis</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.1 Pulmonary embolism <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1820</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.81 [0.49, 6.65]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.2 Symptomatic deep vein thrombosis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1848</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.61 [0.18, 2.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.3 Asymptomatic deep vein thrombosis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>369</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.14 [0.03, 0.61]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.4 Adverse effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1978</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.85 [0.95, 3.59]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.5 Major bleeding <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1451</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (MâH, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.06, 15.72]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.6 Minor bleeding <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1978</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.79 [0.84, 3.84]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span>Â <span class="table-title">Lowâmolecularâweight heparin (LMWH) versus no prophylaxis</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005259.pub5/references#CD005259-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD005259-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 2.</span>Â <span class="table-title">Rivaroxaban versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.1 Symptomatic deep vein thrombosis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>234</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.16 [0.02, 1.29]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.2 Asymptomatic deep vein thrombosis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>234</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.06, 15.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.3 Minor bleeding <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>234</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.63 [0.18, 2.19]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span>Â <span class="table-title">Rivaroxaban versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005259.pub5/references#CD005259-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD005259-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 3.</span>Â <span class="table-title">Lowâmolecularâweight heparin (LMWH) versus compression stockings</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.1 Pulmonary embolism <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1317</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (MâH, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.14, 7.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.2 Symptomatic deep vein thrombosis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1317</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.17 [0.04, 0.75]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.3 Asymptomatic deep vein thrombosis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1317</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.47 [0.21, 1.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.4 Adverse effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.4.1 Pain, tenderness and edema</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1317</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.17 [0.95, 1.43]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.4.2 Major bleeding</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1317</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.01 [0.61, 14.88]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.4.3 Minor bleeding</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1317</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.16 [0.64, 2.08]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span>Â <span class="table-title">Lowâmolecularâweight heparin (LMWH) versus compression stockings</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005259.pub5/references#CD005259-tbl-0004">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD005259.pub5&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD005259-note-0004">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD005259-note-0011">EspaÃ±ol</a> </li> <li class="section-language"> <a class="" href="fa#CD005259-note-0009">ÙØ§Ø±Ø³Û</a> </li> <li class="section-language"> <a class="" href="fr#CD005259-note-0010">FranÃ§ais</a> </li> <li class="section-language"> <a class="" href="ko#CD005259-note-0006">íêµ­ì´</a> </li> <li class="section-language"> <a class="" href="ms#CD005259-note-0008">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pt#CD005259-note-0007">PortuguÃªs</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD005259-note-0005">ç¹é«ä¸­æ</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright Â© 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">Â Â Facebook</a> <a class="a2a_button_x share-button">Â Â X(Twitter)</a> <a class="a2a_button_whatsapp share-button">Â Â WhatsApp</a> <a class="a2a_dd share-button">Â Â View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005259\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005259\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005259\x2epub5\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD005259\x2epub5"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005259\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005259\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005259\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005259\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005259\x2epub5\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD005259\x2epub5"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005259\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005259\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005259\x2epub5\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD005259\x2epub5"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005259\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005259\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005259\x2epub5\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD005259\x2epub5"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=xcg9958b&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD005259.pub5&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD005259.pub5';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">EspaÃ±ol</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">ÙØ§Ø±Ø³Û</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">FranÃ§ais</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">à¤¹à¤¿à¤¨à¥à¤¦à¥</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">æ¥æ¬èª</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">íêµ­ì´</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">PortuguÃªs</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Ð ÑÑÑÐºÐ¸Ð¹</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">RomÃ¢nÄ</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">à®¤à®®à®¿à®´à¯</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">à¸ à¸²à¸©à¸²à¹à¸à¸¢</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">ç¹é«ä¸­æ</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">ç®ä½ä¸­æ</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD005259.pub5/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD005259.pub5/full/es">EspaÃ±ol</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD005259.pub5%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740715285405"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD005259.pub5/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740715285409"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD005259.pub5/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918d835c0d3af446',t:'MTc0MDcxNTI4Ni4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 